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SUMMARY 
 
Introduction 
Parkinson’s disease is the second most common neurodegenerative disease in the world 
today. Postural instability is one the four cardinal signs and causes reduced balance and 
can lead falls. Falls may have significant consequences. In addition PwPD experience 
increasing disability, reduced mobility, fear of falling and reduced quality of life. 
Pharmacology has been the cornerstone of treatment thus far, but may limited in 
treating postural instability. Increasing evidence suggests that physiotherapy and 
exercise improves balance and may reduce falls. There is limited evidence as to which 
type, intensity and frequency of exercise are most beneficial. 
 Aims  
The aim is to assess the impact of a six week balance exercise class on activity 
limitations in PwPD. 
Objectives    
1. Improve balance as measured by the Brief BESTest 
2. Reduce falls rates as measures by falls diary 
3. Increase functional mobility as measured by the Timed Up and Go (TUG), 
Timed Up and Go-Cognitive (TUG-C) and Timed Up and Go- Manual (TUG-
M). 
4. Increase confidence and participation as measured by the Falls Efficacy Scale.  
5. Improve QOL as measured by the Parkinson’s Disease Questionnaire- 39 (PDQ-
39) 
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Methods 
 Single blind randomised control trial. 
 Community dwelling PwPD.  
 Hoehn and Yahr1-4. 
 Independently mobile with and without an aid. 
 
  
Primary Outcome Measure was the Brief BESTtest. 
Secondary measures of interest included MDS-UPDRS (part 2 and part 3), Timed Up 
and Go, Timed Up and Go Cognitive, Timed Up and Go Manual, Falls Efficacy Scale, 
Parkinson’s Disease Questionnaire -39 
 Results 
Non-significant change in balance between groups, significant improvement in ADL 
section of MDS-UPDRS, no change in FOF or HROL 
Conclusions and Implications of findings 
A six week balance exercise programme did not have significant change in balance 
score. The duration of the study may not be of sufficient duration to show an impact. 
  
iii 
 
 
ACKNOWLEDGEMENTS 
 
I would like to sincerely thank my project supervisor Rose Galvin for her invaluable 
support, guidance and encouragement for the entire duration of this thesis. 
I would also like to express my gratitude to the Royal College of Surgeons staff and my 
fellow students. 
To my manager Elaine Barker and all my colleagues from the Physiotherapy 
department in Tallaght hospital I thank you. To Sarah O’Callaghan for stepping in to 
assist with assessment. A special thanks to Antoinette Curley and Anne-Maria Scanlon 
I truly appreciate their unwavering support and understanding throughout the last two 
years. 
A special thank you to all my colleagues in the Neurology department in particular our 
Parkinson’s Disease Specialist Nurse Nicola Kavanagh. 
Thank you to Neurologists Dr Richard Walsh for his assistance with this study, Dr 
Dominick McCabe and Dr Sinead Murphy for facilitating this project. 
To the wonderful participants of this study a very sincere thank you. 
Finally I would like to thank my family and friends for all their encouragement and 
assistance during the last two years, especially my wonderful mother and cousin Mary 
for their constant advice and proof reading for which I am eternally grateful. 
 
 
 
 
iv 
 
 
 
LIST OF TABLES        
Page 
Table 3.1 Hoehn and Yahr Scale      36 
Table 3.2 Mobility Status at Baseline      38 
Table 3.3 Summery of Baseline demographics of each group   39 
Table 3.4 Baseline Outcome Measures      40 
Table 3.5 Parkinson’s Disease Questionaire-39 at Baseline   41 
Table 3.6 Change in scores of Outcome Measures between groups T1 to T2 49 
Table 3.7 Change in score of PDQ-39  between groups T1 to T2  50 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
 
 
LIST OF FIGURES       
Page 
Figure 3.1 Participant Flow Diagram            32                                                               
Figure 3.2 Age statistics for the control and intervention group   34 
Figure 3.3 Years since diagnosis       35 
Figure 3.4 Bar chart of participant’s medication     37 
Figure 3.5 Brief BESTest scores at T1 and T2 in Control and Intervention 43 
Figure 3.6 MDS-UPDRS Part two score at T1 and T2    44 
Figure 3.7 MDS-UPDRS Part three score at T1 and T2    45 
Figure 3.8 TUG scores at T1 and T2      46 
Figure 3.9 TUG-C scores at T1 and T2      47 
Figure 3.10 TUG-M scores at T1 and T2      48 
Figure 3.11 FES scores at T1 and T2      51 
 
 
 
 
  
vi 
 
 
LIST OF APPENDICES        
Page 
Appendix 1 Letter of Invitation to Study Participants   65  
Appendix 2 Patient Information Leaflet     66 
Appendix 3 Patient Consent Form      68 
Appendix 4 Hoehn and Yahr Scale     70 
Appendix 5 MMSE       71 
Appendix 6 Ethics Letter       72 
Appendix 7 Ethics Form       73 
Appendix 8 Data Collection Form      96 
Appendix 9 Brief BEST Test      98 
Appendix 10 MDS-UPDRS       99 
Appendix 11 Timed Up and Go Test     131 
Appendix 12 Parkinson ’s disease Questionnaire – 39   132 
Appendix 13 Falls Efficacy Scale      137 
Appendix 14 Falls Diaries       138 
Appendix 15 Demographic Data Collection Form    140  
  
vii 
 
 
LIST OF ABBREVIATIONS 
 
 
BBS  Berg Balance Scale 
CI  Confidence Interval 
MDS-UPDRS Movement Disorder Society - Unified Parkinson’s Disease Rating Scale 
PD  Parkinson’s disease 
PwPD  People with Parkinson’s Disease 
PDQ-39  Parkinson’s Disease Questionnaire-39 
QoL  Quality of Life 
RCT  Randomised Controlled Trial 
REM  Rapid Eye Movement 
SD  Standard Deviation 
TUG  Timed Up and Go Test 
 
 
8 
 
INTRODUCTION    
 
Parkinson’s disease (PD) is a complex neurodegenerative disorder and the second most 
common neurodegenerative disorder in the world today (Alexander 2004).The majority 
of people with Parkinson’s disease (PwPD) are diagnosed over the age of 60 (Wielinski 
et al 2005), therefore the prevalence increases with age (Gilaldi et al 2001). The number 
of people over 50 years in Western Europe’s five most populous nations who have PD 
was  estimated between 4.1 and 4.6 million in 2005 and is expected to double by 2030 
(Dorsey et al 2007). Parkinson’s disease affects approximately 8000 people in Ireland 
(Parkinson’s disease Association of Ireland 2013). The economic cost of PD across 
Europe is estimated at 13.9 billion per year (Olsen et al 2012). The greatest direct cost is 
for in-patient care, hospitals and nursing home care (Findlay 2007) and the costs 
increase as the disease progresses.  
PD is diagnosed primarily on clinical signs. A reduction in neurons in the substantia 
nigra and the resultant reduction in dopamine leads to symptoms of tremor, rigidity, 
bradykinesia and postural instability. In addition to the motor symptoms non-motor 
symptoms including cognitive decline, rapid eye movement (REM) sleep disturbance 
and anxiety may be present.  As the disease progresses people with Parkinson’s (PwPD) 
face increasing difficulty with transfers, postures, balance, mobility and walking (Keus 
et al 2007).The deterioration in activities of daily living (ADLs) results in reduced 
quality of life (QOL) and independence (Dibble et al 2010). It was reported by Ashburn 
et al (2001) that one third of people in the normal population of over 65s  fall, in 
comparison with two thirds of PwPD living in the community who had experienced a 
fall in the previous year. An increased risk in falls leads to an increase in risk of injuries 
and fracture, especially hip fracture. Injuries from falls may lead to severe and even 
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devastating consequences. Wielinski et al (2005) reported that half of people who fall 
will require medical care. The risk of mortality is 1.8 to 2.3 times higher than the 
normal population (Posada et al 2011). 
The management of PD has centred on pharmacological intervention to date. Despite 
optimum pharmacological management patients still experience a deterioration of body 
function, daily activities and participation (Nijkrate et al 2007). 
There exists a growing evidence base for exercise and physiotherapy interventions for 
PwPD (Keus et al 2007). Physiotherapy interventions including treadmill training (Bello 
et al 2010) cueing strategies (Nieuwboer et al 2007) cognitive movement strategies 
(Morris et al 2009) can improve balance and gait. Lack of consensus exists regarding 
which interventions are most efficacious in terms of content, frequency and duration. 
Studies have been limited by small sample sizes and lack of long term follow-up. In the 
elderly population falls prevention programmes that are multifactorial are demonstrating 
favourable results in reducing rates of falls.  Sherrington et al (2008), reports that highly 
challenging balance exercises may provide improvements in balance performance in the 
elderly. PwPD may present with gait impairments. The addition of a dual task while 
carrying out a mobility task can impact gait speed and stride length, to greater extent 
than age matched controls (Canning et al 2008). Cognition plays a vital role in balance 
and mobility. Cognitive impairment is common in PD and impacts negatively on 
balance.  Brauer and Morris (2010) suggest incorporating dual task training to improve 
gait activity.  
PD is a chronic progressive neurological condition and PwPD will face an inevitable 
increasing disability and reduced physical activity. Exercise has been shown to have a 
positive effect on balance and quality of life (Goodwin et al 2008). Animal studies are 
10 
 
yielding tentative evidence for the role of exercise as a neuroprotective element (Hirsch 
and Farley 2009) . Physiotherapists play an important role in promoting physical 
activity. 
An increasing elderly population and an increase in numbers of pwPD will impact on 
the economy and health services.  Therefore, effective interventions are required to 
improve balance, reduce activity limitations and increase participation in this 
population. 
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CHAPTER 1    LITERATURE REVIEW 
 
1.1 Over view of aetiology of PD 
  
PD is a multisystem neurodegenerative disorder in which the progressive loss of the 
midbrain dopamine neurons leads to the motor signs of PD (Alexander 2004). Neurons 
in specific parts of the cortex, thalamus and spinal cord are also affected. It was 
historically viewed as a motor disorder, however it is now known that the non- motor 
symptoms may be as severe and have as large an influence on the individual.  The non-
motor symptoms include, reduced attention and cognition which lead to an increased 
risk of falls due to difficulty with dual tasking (Kelly et al, 2012). 
 Rating scales are widely used in clinical practice and research to track the disease 
progression. The Hoehn and Yahr (H&Y) rating scale is the most well-known which 
rates from zero (no symptom) to five (unable to walk) (Hoehn and Yahr 1967). Score of 
one to two indicate milder disease without postural instability. 
 
1.2 Clinical manifestations of PD 
 
The four cardinal signs of Parkinson’s disease are tremor, rigidity, bradykinesia and 
postural instability. Postural instability may be the most debilitating feature (Nocera et 
al 2009) and leads to further disability. Balance can be defined as ability to maintain the 
body’s centre of gravity over base of support during quiet standing and during 
movement (Kara et al 2012) and is essential for any locomotor activity. Balance 
requires the coordination of biomechanical, sensory, motor and the central nervous 
systems. 
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1.3 Falls and PD 
 
The ability to maintain upright posture and balance is of utmost importance in daily life. 
PwPD have difficulty maintaining equilibrium in standing but also moving between 
positions and during dynamic movement (Kara et al 2012) which may lead to falls. 
Rates of falls vary in the literature from 35-90% for a single fall and 18-65% for 
recurrent falls (Allen et al 2013). The causes of falls in PD are multi-factorial. In a 
recent systematic review Allen (2013) identified balance impairment as a major 
contributor to falls. PwPD who fall are significantly affected physically and 
psychologically (Plotnik et al 2011). Wielinski et al (2005) highlighted that 65% of 
those people who fall will experience an injury and 33% will sustain a fracture.  
Postural instability and recurrent falls are also associated with fear of falling (Mak and 
Pang 2009) and in turn can lead to reduced activity levels resulting in decreased muscle 
strength and cardiovascular fitness (Canning et al 2009). Falls are also related to loss of 
independence, increased hospitalisation and nursing home placement (Plotnik 2009). 
Risk factors for falls in PD include history of falls (Pickering 2007), freezing of gait 
(Latt et al 2009), leg muscle weakness (Bloem 2001) and postural instability (Kerr et al 
2010). 
A history of falls has been found to be a strong predictor of future falls (Pickering 2007) 
and it is therefore of utmost importance that falls prevention be implemented as early as 
possible (Shen and Mak 2012). Physiotherapy for PwPD aims to maximise function and 
independence, reduce secondary complications through movement rehabilitation 
(Tomlinson et al 2012). In a recent systematic review of 33 randomised controlled trials 
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(RCTs) by Tomlinson and colleagues (2012) comparing physiotherapy with no 
intervention, short term improvements were reported for walking measures and balance  
 
related outcomes. There was a wide variety of interventions in the review and no 
consensus on which was most effective. Interventions included general physiotherapy, 
exercise, treadmill training, cueing, dance and marital arts. Preventing falls is a priority 
for PwPD, however most are referred to physiotherapy after falling. It is of utmost 
importance to determine which interventions are the most beneficial and what is the 
optimal delivery mode to reduce falls risk (Keus et al 2009). 
 
1.4 Postural Instability in PwPD 
 
PwPD who present with postural instability have reduced balance and have difficulty 
maintaining upright position especially when standing and walking (Kim et al 2013). It 
can occur at any stage of the disease and is associated with falls, poor mobility, 
disability and reduced quality of life (QOL) (Allen et al 2011). Postural instability 
worsens as the disease progresses and leads to an increased risk of falls (Kim et al 
2013). Studies suggest that in addition to the cardinal signs i.e. rigidity, bradykinesia 
and impaired postural reflexes, there exists dysfunction in the vestibular, proprioceptive 
and visual systems (Toole et al 2005). 
Schoneberg et al (2013) suggested balance dysfunction could be characterised into four 
postural control systems including  balance during quiet stance, reactive postural 
adjustments to external perturbations, anticipatory postural adjustments (APA’s) in 
preparation for voluntary movements and dynamic balance during movements such as 
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walking. A reduction in postural reflexes, increase postural sway, attention deficits and 
sensory deficits may all be evident in PwPD (Kim et al 2013) which highlights the 
complex pathophysiology and consequently the challenges encountered in management 
of the disease. Pharmacological intervention e.g. dopamine has been the cornerstone of  
treatment. However it has little effect on gait and postural instability and it has been 
suggested that it may in fact worsen the symptoms (Horak 1996). There is moderate 
evidence that physical activity and exercise can improve performance on measures of 
postural instability and balance-related activity in people with mild to moderate 
Parkinson’s (Dibble et al 2009) however the evidence is insufficient to determine if 
improvement in balance translates to reduction in falls (Kim et al 2013). 
 
1.5 Balance exercise as intervention in Parkinson’s disease 
 
Dibble et al (2009) in a systematic review assessed the impact of physiotherapy 
interventions on balance-related outcomes across the categories of health and disability 
defined by the World Health Organisation International Classification of Functioning, 
Disability and Health (ICF) model (World Health Organisation 2012). Interventions 
included traditional physiotherapy, balance training, whole body vibration and imagery. 
There was no evidence that interventions improved participation, and the 16 studies 
were limited to English language. Nevertheless, moderate evidence illustrated that 
interventions improved balance- related outcomes. Two research studies (Protas et al 
2005; Ashburn 2007) evaluating falls risk concluded that there was insufficient 
evidence to demonstrate a reduction in falls despite positive trends in outcomes. In a 
RCT of 172 PwPD by Ashburn et al (2007) the intervention involved an exercise 
programme in the participant’s home.  The balance exercises were not defined, thus 
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making the study difficult to reproduce. In a systematic review and meta-analysis of 14 
studies of exercise intervention for PwPD Goodwin et al, (2008) reported that exercise 
demonstrated improvements in physical functioning, health related Quality of Life 
(QOL), strength, balance and gait speed. Balance was measured in five studies and four 
showed a significant improvement in balance measures. 
In a more recent meta-analysis by Allen et al (2011), 17 studies were evaluated to 
determine the effects of exercise and motor training on balance and falls. In the two 
studies that measured falls rate (Ashburn 2007; Nieuwboer 2007) there was no evidence 
of a reduction in falls due to the intervention. In the latter study a proto-type device 
provided three different cues including auditory, visual and somatosensory during gait 
practice. Conditions included start and stop, change direction and varying surfaces and 
dual task practice. The primary outcome measure was the composite postural and gait 
score of the United Parkinson’s Disease Rating Scale (UPDRS), falls rates were 
measured with a falls diary. 
In the studies in Allen et al (2011) where balance was measured there was a positive 
trend towards balance related outcomes.  In the five studies that included highly 
challenging balance programmes a greater effect size on balance related outcomes was 
demonstrated but this did not reach statistical significance. (Hedges’g,0.62; 95%CI , 
0.13-1.10, p=0.03). 
Postural sway is impaired in PwPD and increasing number of studies are using force 
platforms to measure balance and postural sway in the PD population. In a study by 
Kara et al (2012), 17 participants underwent a supervised exercise programme including 
both static and dynamic exercises for 12 weeks. Balance exercises including reduced 
base of support in standing, forwards and sideways stepping and walking and graded 
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reaching activities were components of the supervised exercise programme. In addition 
gross and fine motor coordination exercises were prescribed as was cueing strategies to 
reduce freezing. Assessments were carried out pre and post 12 week intervention using 
the balance master to measure static and dynamic balance. Tests included the modified 
clinical test of sensory interaction on balance (mCTSIB) and the unilateral stance test, 
Limits of Stability (LOS), STS, tandem walk and step/quick turn (SQT) measured 
dynamic balance. Statistically significant differences in favour of the intervention group 
were found on measures of unilateral stance and LOS indicating an improvement in 
dynamic balance. There was no difference in disability as measured by the UPDRS. 
This study is limited due to small numbers and lack of a control group. The authors 
stated that participants received a falls diary but no results of the rates of falls were 
reported.  
Gobbi et al (2009) compared two exercise interventions where the Berg Balance Score 
(BBS) and Timed Up and Go (TUG) were the primary outcome measures in a group of 
24 patients. The interventions were a multimodal exercise programme aimed at 
developing the participant’s functional capacity or an adaptive programme focusing on 
changing the effects of inactivity. Interventions were carried out over a six month period 
however the former was more frequent with three sessions a week rather than one.  Both 
groups improved, but there was no difference between group improvements. This 
highlighted the need for further studies with greater numbers of participants to 
determine the optimal dose and content of the intervention.  
In a pragmatic parallel group RCT of 130 individuals with a history of falls the authors 
compared usual care to a PT programme (Goodwin et al  2011).The intervention 
consisted of balance and strength exercises from established falls prevention 
programmes for the elderly (Skelton 2005). There was a non-significant reduction in 
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falls rates in the intervention group. However the authors noted that the study was 
underpowered to detect difference in falls rates. Hirsch et al, (2003) conducted a study 
of limited sample size (n=15) but reported improvement in balance, as measured by 
sensory orientation test (SOT), following ten weeks intervention of high resistance 
training and balance exercises in comparison to balance exercises only.  
The majority of physiotherapy studies are based in outpatient hospital departments, 
however Frazzitta et al (2013) evaluated four week in-patient rehabilitation with one 
year follow up on balance and gait. The twenty participants had PD stage three on 
Hoehn and Yahr scale and received a multidisciplinary rehabilitation treatment 
intervention. Physiotherapy intervention included stretches, balance exercises on a 
stabilometric platform and treadmill training over three sessions lasting an hour five 
days a week. There was a statistically significant improvement in balance and gait 
measures post intervention and the improvements in gait score were maintained at one 
year follow up.  
Tai Chi has been adapted for use in PwPD also, particularly the balance component 
involving weight shifting, movement of centre of mass over base of support, anterior-
posterior sway and lateral stepping. In a randomised controlled trial (RCT) by Li et al 
(2012), Tai chi was compared to a resistance training or stretching programme in a PD 
population (n=195) over a six month intervention period.  There was an improvement in 
the primary outcome measures of postural stability, in comparison to the stretching 
group with a reduction in falls by 67%. This is the only study that has demonstrated a 
reduction in falls with exercise intervention. The type of exercises described earlier may 
have contributed to improvement in postural control and walking ability.   
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The effects of balance training which included exercises that incorporated feed forward 
and feedback postural control were evaluated by Smania et al (2010) in a RCT of 64 
participants. The intervention consisted of 21 treatment sessions, three times per week 
for seven weeks. Improvements in balance were maintained at one month in the 
intervention group as measured by the Berg Balance Scale.  
Following an intervention of repetitive step training with visual cues, three times 
weekly for eight weeks, Shen and Mak (2012) demonstrated improvements in LOS and 
the posture and gait sub score of the Unified Parkinson’s Disease Rating scale (UPDRS) 
motor score. The participants in this small study had no history of falls in the past year. 
This highlights the need for further studies of PwPD with greater disease severity. The 
studies above support physiotherapy and balance interventions to improve balance 
related measures including those as measured by force platforms. Studies that include 
dynamic balance appear to have greater effect on outcome. Studies are limited by 
sample size, therefore further studies with larger sample sizes powered to detect change 
in falls rates are required. 
 
1.6 Exercise interventions in the elderly 
 
Falls prevention programmes for the elderly are generally multi-factorial and include 
balance as a component. Increasing numbers of studies for PwPD are extracting 
components of falls exercises programmes and utilising as the intervention (Gobbi 
2009, Goodwin 2011). The Otago exercise programme is an example of this and is 
primarily a balance exercise programme that has demonstrated a 35% reduction in falls 
and falls related injury in the elderly (Roberston et al 2002). A meta-analysis of 44 
studies by Sherrington et al (2008)  assessing exercise and balance in older people 
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demonstrated that exercise reduced falls by 17%  (rate ratio 0.83 95% CI 0.7,-0.91). 
Highly challenging exercises that reduced the base of support provided the greatest 
reduction in falls rate (rate ratio 0.58 95%CI 0.48-0.69).   
 
1.7 Dual task training in PD 
 
Activities of daily living (ADLs) often require people to perform more than one task at 
a time (Vanshika and Ravi 2012). When performing multitask activities, PwPD are 
more likely than healthy subjects to shift attention away from the balance task, which 
can lead to falls (Bloem et al 2006). PwPD, who have a high risk of falls, are more 
sensitive to dual task effects as a result of poor executive function (Plotnik et al 2011).  
In a study examining gait under dual task conditions Rochester (2004) reported that 
speed and step length were reduced. Vanshika and Ravi (2012) evaluated the effects of 
a balance training programme in which the intervention included balance and cognitive 
tasks. Measures of falls were not reported but improvements in ADLs and balance 
measure were demonstrated. 
Brauer and Morris (2010) assessed 20 PwPD after a one-off session of dual task 
walking training; improvements in gait were demonstrated as measured with the Gaitrite 
gait analysis system. The intervention included walking trials under seven different 
conditions. These consisted of gait alone or an addition of a cognitive or manual task, 
different domains and difficulty level. Intervention included walking with working 
memory language to include counting forward and backwards, carrying objects, 
manipulating coins, controlled oral word association tests, auditory choice and visio-
spatial task. Variable priority training whereby prioritisation alters between improving 
step length and task performance during training (Silsupadel et al 2006). Improvements 
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in gait parameters while training one task were transferable to another task, but the 
study is limited by lack of follow up.  
Older adults demonstrate reduced ability to dual task over time. In a small study by 
Buragadda et al (2012) whereby 30 older adults were trained over four weeks with dual 
task training under fixed or variable priority set, improvements in balance measures  
were demonstrated. Therefore, dual task training under variable priority may be more 
effective at improving balance than that under fixed priority Canning et al (2008) 
investigated the feasibility of multiple-task walking training in five people with H &Y 
stage 2-3, using VAS for visual and mental fatigue. The authors demonstrated that it 
was feasible in this population. Tasks included walking training with manual (e.g. 
carrying a plate) and cognitive (e.g. counting backwards) tasks. Walking speed 
measures by Gaitrite improved however this study lacked a control group and was also 
limited by number of participants. 
1.8 Conclusion 
 
Studies have demonstrated that physiotherapy interventions improve balance and gait 
outcomes. Literature suggests that highly challenging balance exercises may be most 
effective at improving outcomes. There exists less evidence that exercise results in fall 
reduction. Studies are limited by small sample size, lack of follow-up and inconsistent 
measuring of falls rate. There is heterogeneity with respect to the optimal frequency, 
intensity and timing of the interventions. It is now known that cognition plays an 
important role in gait and balance. Increasing studies are demonstrating positive 
outcomes following dual task interventions in the elderly; this may be applicable to the 
PD population. The aim of this study is to evaluate the effect of a balance class on 
activity limitations in PwPD in comparison to no intervention. 
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CHAPTER 2       METHODOLGY 
 
2.1Aims and Objectives 
 
The aim of this randomised controlled trial was to examine the effect of a six week 
balance exercise class on activity limitations in people with Parkinson’s when compared 
to routine care. 
Objectives 
To determine if a one hour weekly balance exercise class delivered over six weeks for 
community dwelling participants with idiopathic Parkinson’s disease versus routine care 
will 
1 Improve balance as measured by the Brief BESTest (Primary Outcome 
Measure). 
2 Reduce falls rates as measured by falls diary. 
3 Increase functional mobility as measured by the Timed Up and Go  (TUG), 
Timed Up and Go-Cognitive (TUG-C) and Timed Up and Go- Manual (TUG-
M). 
4 Increase confidence and participation as measures by the Falls Efficacy Scale.  
5 Improve QOL as measured by the Parkinson’s Disease Questionnaire- 39 (PDQ-
39). 
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2.2 Hypothesis 
 
HA – balance class will improve balance related measures and confidence, thus 
reducing activity limitations and increasing participation in everyday life. 
Hō- balance class will have no effect on balance related measures and confidence, thus 
no impact on activity limitations and participation in everyday life. 
2.3 Study Design 
 
2.3.1 Study design 
 
An single blind randomised controlled trial was conducted to ascertain the impact of a 
balance exercise class on community dwelling PwPD living in southwest Dublin using 
the Consort guidelines and flow diagram (CONSORT guidelines 2010).  The control 
group did not receive any formal physiotherapy intervention for three months prior to 
the intervention and during the study. They were advised to continue activity as normal 
for the duration of the study. They were offered the intervention on completion of the 
study. 
 
2.3.2 Statistical powering  
 
A sample size calculation was performed based on the primary outcome measure, which 
was the Brief BEST test (Duncan et al 2012). The number of participants required to 
produce a statistically meaningful change in activity levels using the Brief BEST test 
were calculated using the power calculation for the comparison of means in two 
independent samples (Daly and Bourke 2000). The formula used to determine the 
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number of participants required in the RCT involved the prediction of the standard 
deviation (σ) for the Brief BEST test and an anticipated significant clinical change (Δ).  
The value for the σ was obtained from a study by Duncan and et al (2012). The authors 
reported the baseline standard deviations of the groups ranging from 4.7 to 5.9. The 
more conservative value of 4.7 points was chosen and this figure was used to represent 
the σ of the Brief BEST test in the proposed study. For the Brief BEST test, the between 
group difference reported in the Duncan et al (2012) paper was used and the clinically 
meaningful difference between the groups was set at 6 points.The score range for the 
Brief BestEST zero to 24. The value of the constant ‘K’, 7.8, was dictated by the 
significance level chosen for the study, in this case a two-sided significance level of 5% 
with an 80% chance of detecting a treatment effect.  
Based on a two group comparison (Daly and Bourke 2000), power calculations 
indicated that  minimum of 20 participants were required to detect an increase of 6 
points on the Brief BEST test at a two-sided significance level of 5% and a power of 
80%, assuming a σ of 4.7 points. Using this output, it was decided that a sample size of 
24 participants would be recruited to the proposed RCT to allow for attrition of 20%. 
The sample size calculation is detailed in Figure 1. 
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Figure 1: Calculation of the sample size required for the RCT 
Number of participants required in each of the comparison groups must be greater than 
the value calculated using the following formula (Daly and Bourke 2000) 
 
2 (Constant K) (σ of the Brief BEST test)2 
(What is considered to be a clinically significant change in the Brief BEST test)
2
 
 
2 (7.8 for two sided test with significance level of 0.05) (4.7)
2 
(6)
2
 
 
2 (7.8) (22.09) 
36 
 
10 participants per group 
 
Therefore in order to detect a clinically significant change of 6 points on the Brief 
BEST test, a minimum of 20 participants were required in total for the RCT 
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2.4 Subjects  
 
2.4.1 Recruitment 
 
The participants were recruited from the physiotherapy department neurological 
physiotherapy waiting list for out-patient physiotherapy and physiotherapy PD review 
database in Tallaght Hospital. Patients from the database may have attended for 
physiotherapy intervention and a PD class in the past, however not within the previous 
three months. A gatekeeper contacted the participants by telephone to determine if 
participants were eligible, subsequently interested in participating in the study. A brief 
screening process followed to determine eligibility. If the participants agreed to 
receiving further information about the nature of the project an information pack 
containing a cover letter (appendix 1 ), participant information leaflet (appendix 2) and 
consent form (appendix 3 ) was sent to all interested PwPD . Participants were 
contacted by the gatekeeper by telephone after one week to gain verbal consent. 
Recruitment ran from September 2013 to February 2014 when the required 24 
participants were recruited. 
2.4.2 Inclusion/ Exclusion Criteria 
 
Participants were included if they had a diagnosis of idiopathic Parkinson’s disease, 
diagnosed by a consultant neurologist and were independently mobile with or without 
an aid. Stages 1-4 of the Hoehn and Yahr disease severity were included (appendix4).  
Participants were excluded if they had non-Idiopathic Parkinson’s disease, 
cardiovascular or orthopaedic conditions that limited mobility. Participants were 
excluded if they scored less than 24 on the Mini Mental State Examination (MMSE) 
(appendix 5) and if they were unwilling or unable to provide written consent. Subjects 
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were excluded if they had attended for physiotherapy intervention in the previous three 
months. 
 
2.4.3. Group Allocation  
 
To minimise the possibility of recruitment bias, a person independent of the recruitment 
process (RG) completed random group allocation with consecutive individuals who had 
given written informed consent. With random assignment, the aim was give all 
participants an equal chance of being assigned to either the experimental group or the 
control group. By assigning participants at random, it was possible to infer that any 
observed group differences were attributable to the independent variable i.e the exercise 
intervention. Computer generated random numbers were created and placed in sealed 
envelopes by this independent person. These numbers were stored in the pre-sealed 
envelopes in a locked drawer in the Department of Physiotherapy. Allocation was 
revealed after recruitment – following contact from the treating therapist, the 
independent person (RG) opened the next envelope in the sequence and gave the 
randomisation information to the treating therapist. Each envelope was opened on 
enrolment of an eligible participant. After allocation was revealed to the treating 
therapist, the appropriate intervention/control was organised. 
 
2.5 Ethical Considerations 
 
2.5.1 Ethical Approval 
 
Ethical approval was obtained from the Tallaght/St James Hospital research &ethics 
committee reference number; 2013/08/06 Chairman’s Action (appendices 6 & 7). 
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2.5.2 Confidentiality 
 
Confidentiality of data was ensured as all participants were given a coded number. All 
data was stored in a locked filing cabinet in the Physiotherapy Department, which the 
author and Physiotherapy manager only had access to. All data were coded and stored 
on the author’s password protected computer in the physiotherapy department. The 
author and RCSI supervisor (RG) had access to the coded data. The data will be 
destroyed after seven years in accordance with the ethics committee policy. 
Permission to conduct this study was given by Mrs Elaine Barker, Acting Physiotherapy 
Manager and Dr R Walsh Consultant Neurologist, Tallaght Hospital. Two additional 
Neurologists Dr Dominick McCabe and Dr Sinead Murphy agreed to allow their 
patients to participate in the study. 
2.5.2 Participant Safety  
 
As with any exercise intervention there is a small risk of falls. The group was 
supervised by the author and a physiotherapy assistant. Standard risk assessments were 
undertaken prior to the class according to local Health and Safety hospital policy. 
2.6 Assessment 
 
2.6.1 Procedure 
 
All participants were assessed by three blinded assessors who were qualified 
physiotherapists at baseline and after the intervention, therefore limiting detection bias 
(appendix 8). 
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The intervention was delivered by the author and the participants attended the 
physiotherapy gym for one hour weekly for six weeks. 
 
2.7 Outcome measures  
 
2.7.1 Primary outcomes measure:  
 
Brief BESTest is a valid and reliable measure of balance and predictor of falls in PwPD 
(Duncan et al 2012). (appendix 9). It is an abbreviation of the longer Balance Evaluation 
Systems Test (BESTest) that examines balance performance in six systems of postural 
control: mechanical constraints, limits of stability, anticipatory postural adjustments, 
and postural responses to induced loss of balance, sensory orientation and gait (Horak et 
al 2009). The Brief BESTest has fewer items but has representations from each section 
of the BESTest (Padgett et al 2012). It has similar reliability to the Mini Best in the 
neurological population and is more sensitive to change than the original version 
(Padgett et al 2012).  
 
2.7.2 Secondary Outcome Measures: 
 
Impairment; 
The MDS-UPDRS (Movement Disorder Society Unified Parkinson’s Related Disease 
Rating Scale) - (Goetz et al 2008) (appendix 10) is a measure of disease severity and 
was developed from the UPDRS.It consists of four sections. In this study part two, 
(motor impact of experiences of daily living) and part three (motor examination) were 
measured. This scale has high internal consistency and high correlation with the original 
scales (Goetz et al 2008). 
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Activity limitation; 
The TUG is measure of functional mobility It is widely used in physiotherapy studies 
for assessing functional mobility in PwPD . The addition of extra components to this 
test e.g counting backwards in threes and carrying an object  have derived further  
tests (TUG-C and TUG-M), which  provide information on dual tasking (Campbell et al 
2003) (appendix 11). 
 Participation restriction; 
The PDQ-39 is a disease specific measure of subjective health status. (appendix 12). It 
has been proven to be valid and reliable in this population (Jenkinson et al 1997). 
 The Falls Efficacy Scale (FES) measures balance confidence with ADLs and is valid 
and reliable in this population (Nilsson et al 2010) (appendix 13).  
Additional measures: 
A detailed falls history of falls in the previous six months was obtained. Participants 
were required to keep a falls diary (appendix 14) during the trial. Falls were defined as 
‘an unexpected event in which the participant comes to rest on the ground floor or lower 
level’ (Morris at al 2009). 
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2.8 Intervention 
 
The intervention consisted of a one hour once a week at light to moderate intensity 
exercise, including five to ten minute warm up cool down period. Each group consisted 
of six to eight participants.  
The programme consisted of balance exercises, including feed forward and feedback 
postural control. Exercises included shifting weight onto toes and heels, narrowing base 
of support, standing on unstable surfaces, walking over an obstacle course (Smania et al 
2010). Exercises were progressed to include cognitive and motor tasks, e.g. counting 
while doing the exercise or carrying an object (Canning et al 2008, Conradsson et al 
2012). Standing on foam and uneven surface was included.  
 
 
2.9 Statistical Methods 
 
2.9.1 Data Collection 
 
Baseline demographics to include age, years since diagnosis, disease severity and 
mobility were recorded. Further information including medication and timing of 
medication prior to the assessment was sought.  (Appendix 15). 
2.9.2 Statistical Analysis 
 
 Descriptive statistic in the form of tables and graphs were used to record 
baseline demographics. Data was tested for normality using the Shapiro Wilks 
test to determine if the data were normally distributed. 
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 To determine if there was significant difference in change in the scores from  pre 
(T1)  to post ( T2) assessment between groups an Independent T-Test was 
utilised. 
 To determine if there was a difference between baseline and post intervention a 
paired T test was used. 
 All tests were completed with a 0.05 level of significance.  
 Data was analysed using SPSS  (version 21, IBM Corportation 2012). 
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CHAPTER 3    RESULTS 
 
The aim of this study was to determine the effects of a six balance exercise class on 
activity limitations in people with idiopathic PD when compared to no intervention. The 
objectives were specifically to determine if the balance class would improve balance 
measures and  reduce falls rates, improve functional mobility, increase confidence and 
participation and thus improve QOL. 
The primary outcome measure was the Brief BEST Test. The secondary outcome 
measures of interest were: 
1. The rate of falls- recorded with falls diaries. 
2. Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-
UPDRS part 2 (motor experiences of daily living ADLs) and section three 
(motor examination)). 
3. Timed Up and Go (TUG), Timed Up and Go-Cognitive (TUG-Cog) and the 
Timed Up and Go –Manual (TUG-manual). 
4. Falls Efficacy Scale (FES). 
5. Parkinson’s Disease questionnaire -39 (PDQ-39). 
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   Figure 3.1 Participant Flow Diagram 
Invited to participate (n=38) 
Assessed for eligibility (n=27) 
Randomized (n=26) 
Declined to participate (n=8).  
 Did not require PT at this (n=1) 
 Class time not suitable (n=2) 
 Difficulty attending hospital appointments (n=1) 
 Unable to attend  due to work (n=1) 
 Unwell (n=1) 
 Required mobility assistance, 1:1 intervention 
(n=2)  
Withdrawal (n=3) 
 Unwell (n=1) 
 DNA for assessment (n=2) 
 
 
Allocated to intervention (n=13) 
 Received allocated 
intervention (n=12) 
 Declined to participate 
further (n=1) 
Allocated to control (n=13) 
 Received allocated 
intervention (n=12) 
 Declined to participate 
further (n=1) 
 
Lost to follow up (n=1) 
(unwell) 
Lost to follow up (n=3) 
(unwell) 
 
Analysed (n=12) Analysed (n=12) 
 
Excluded (n=1) 
 Not meeting inclusion criteria 
(n=1) 
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3.1.1 Screening 
 
Participants were recruited between September 2013 and January 2014. In total, 38 
subjects were invited to participate in the study. Eight declined to participate in the 
study and the reasons included are displayed in Figure 3.1.  
3.1.2 Withdrawal and Drop-outs 
 
One patient required medical review prior to commencement of the trial. Two 
participants agreed to participate but did not attend for assessment. Both were offered an 
additional appointment however both did not attend. Twenty seven attended for 
assessment. Four participants did not attend for reassessment at T2.  
3.1.3 Excluded participants 
 
One participant was excluded as they did not fulfil the criteria, MMSE < 24. Two of the 
participants who consented to take part declined after attending for assessment at T1. 
3.1.4 Allocation 
 
Single blinded randomisation procedures allocated 12 participants to the intervention 
group and 12 participants to the control group. 
3.2 Description of baseline variables of the participants 
 
This section contains description of the 24 participants included in the RCT. The 
participants are described according to group allocation. The following baseline 
variables are described: gender, age, years since diagnosis, H&Y scale, mobility status. 
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3.2.1 Gender 
 
There were 6 females and 6 males in the control group and 8 females and 4 males in the 
intervention group.  
3.2.2 Age   
 
The mean age of the control group was 68.83 years with a standard deviation (SD) of 
6.28 years (range 60 to 81 years). The mean age of the intervention group was 67.42 
years with a SD of 4.64 years (range 61-74). 
 
 
Figure 3.2: Age statistics for the control and intervention group 
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 3.2.3 Years since diagnosis  
The mean number of years since diagnosis of the control group was 8.75 with a SD of 
5.86 years (range 2-18 years). The mean number of years since diagnosis of the 
intervention group was 6.53 with a SD of 5.48 years (range 0.5 -16 years). 
 
  
 
Figure 3.3 Years since diagnosis - Descriptive statistics of years diagnosed 
for control and intervention group 
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3.2.4 Hoehn &Yahr Scale 
 
Disease severity ranged from one to four on the Hoehn and Yahr rating scale. Table 3.1 
describes the groups in more detail. 
Table 3.1 Hoehn and Yahr score of both control and intervention group 
Hoehn and 
Yahr stage 
Control 
Number of participants (%) 
Intervention 
Number of participants 
(%) 
1 6 (50) 7 (58.3) 
2 4 (33.3) 1 (8.3) 
3 1 (8.3) 4 (33.33) 
4 1 (8.3) 0 
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3.2.5 Medication 
 
All participants were taking Parkinson’s specific medication (figure 3.4). The majority 
of participants were on a form of Levodopa or a dopamine agonists (DA). The other  
categories of medication used were monoamine oxidase- B (MAO-B) inhibitors and 
catechol-O-methyl transferase (COMT) inhibitors. 
 Participants reported whether the medication was providing adequate symptom relief as 
‘ON’ when assessed. At T1 n=20 reported status as ‘ON’. At T2 of the 20 participants 
that attended for assessment 18 reported ‘ON’, 2 were not recorded. 
 
Figure 3.4 Bar chart of participants’ medication 
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3.2.6 Mobility status 
 
Mobility status was recorded on all 24 participants who completed the T1 assessments. 
All participants were independently mobile indoors and outdoors with or without a 
walking aid. The majority of participants of the total sample did not use any aid 
(63.5%). Further details of mobility status can be found in table 3.2 
Table 3.2 Mobility status at baseline 
Mobility Status Control 
Number of participants 
(%) 
Intervention 
Number of participants 
(%) 
No walking aid 7 (58.3) 8 (66.7) 
Walking stick 4 (33.3) 2 (16.7) 
Walking stick outdoors 1 (8.3) 0 
Three wheel walker 0 1 (8.3) 
Four Wheel walker n= 0 n= 1(8.3) 
 
 
3.2.7 Mini Mental State Examination 
 
Inclusion criteria required MMSE of greater than 24/30. The mean MMSE of the 
control group was 27.58 with a SD of 2.23 (range 24-30).The mean MMSE of the 
intervention group was 27.75 with a SD of 2.3 (range 24-30).   
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3.2.8 History of falls in the six months prior to this study  
 
The mean number of falls reported by the control group was 0.67 with a SD 1.23, (range 
from 0-3). The mean number of falls of the Intervention group was 0.67 with a SD of 
1.37, (range of 0-4).  
3.2.9 Baseline Demographics 
 
Table 3.3 Summary of the baseline demographics of each group. 
Variables Control Group Intervention Group 
Number of participants 12 12 
Mean age (SD) 68.83 (6.28) 67.42 (4.64) 
Gender (F:M) 6:6 8:4 
Disease duration 8.75 (5.86) 6.53 (5.48) 
History of falls in 6/12, 
mean (SD) 
0.67 (1.23) 0.67 (1.37) 
 
3.3 Baseline Outcome Measures 
 
The baseline outcome measures were administered by three physiotherapists who were 
blinded to group allocation. All outcome measures were administered in the 
physiotherapy gym using a standard protocol and battery of assessments (appendices 8-
15).The baseline descriptive statistics of the different outcome variables are presented in 
Table 3.4. The CONSORT guidelines were followed during the study, thus limiting 
bias. By virtue of random sampling baseline variables should be similar (CONSORT 
2010). 
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The Brief BESTtest was similar at baseline for both groups but had a large range. MDS-
UPDRS was similar for both groups, The TUG-cognitive had a large SD and 
subsequent wide range. Outliers are evident in the boxplots below. 
Table 3.4 Baseline Outcome Measures 
Outcome 
Measure 
Control Group 
n=12 
Intervention Group 
n=12 
Mean SD  Range Mean SD Range  
Brief BEST 
(0-24) 
14.83 6.66 2-22 14.75 6.62 3-23 
MDS-UPDRS 2 
( 0-52) 
12.08 8.77 1-30 10.83 6.19 1-22 
MDS-UPDRS 3 
( 0-132) 
24.58 11.35 7-45 19.42 8.02 6-32 
TUG (secs) 14.5 8.61 6-37 13.42 6.61 8-31 
TUG-C (secs) 19.67 12.66 7-52 16 8.10 9-37 
TUG-M (secs) 16.58 11.75 7-48 15.25 7.34 8-35 
FES (0-64) 26.5 7.12 16-38 26 9.98 16-47 
Brief BEST: Brief BESTest, MDS-UPDRS: Movement Disorder Society Unified 
Parkinson’s Disease Rating Scale, TUG: Timed Up and Go, TUG-C: Timed up and Go 
Cognitive, TUG-M: Timed Up and Go Manual, FES: Falls Efficacy Scale        
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3.3.2 Parkinson’s Disease Questionnaire 39  
 
The PDQ39 is a self-reported questionnaire of HRQOL. The baseline measures of each 
subsection and index score of the control group and intervention are described in Table 
3.5. Table 3.5 Parkinson’s Disease Questionnaire 39 at Baseline 
PDQ-39 
(0-100) 
Control Group 
(n=12) 
Intervention Group 
(n=12) 
Mean SD Range  Mean SD Range 
Mob 42.33 13.90 24-60 34.67 13.14 20-56 
ADL 40 17.52 20-76.67 33.33 9.85 20-46.67 
EMOT 40.83 16.21 20-73.33 33.89 10.43 20-50 
S 29.58 11.37 20-55 27.08 8.38 20-40 
S S 22.78 6 20-40 26.94 18.66 20-83.33 
Cog 45.83 12.40 25-70 27.92 7.82 20-40 
Comm 27.22 7.22 20-40 26.67 6.35 20-40 
Body Discomfort 46.11 18.30 26.66-
86.67 
40.55 17.86 20-73.33 
PDSI 36.84 8.04 26.66-
86.67 
31.25 6.98 22.92-48.97 
Mob: Mobility, ADL: Activities of Daily Living, EMOT: Emotions, S: Stigma, SS: 
Social Support, Cog: Cognition, Comm: Communication, BD: Body Discomfort, 
PDSI: Parkinson’s Disease Summary Index. 
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3.4 Treatment fidelity 
 
The control group did not get any physiotherapy for the duration of the study period. 
The mean number of classes attended by the intervention group was five (SD=1.48) 
(from a total of six classes). The attendance ranged from two to six classes. Six 
participants (50%) attended all six classes, four (33.3%) attended five classes, the 
remaining two participants attended two classes. 
 
3.5 Post Intervention outcome variables 
 
3.5.1 Primary Outcome measures: Brief BESTest 
 
The maximum score for the Brief BESTest is 24.The mean Brief BESTest score for the 
control groups at T2 was 15.83 with a SD of 5.83 points (range 2-24). The mean Brief 
BESTest at T2 for the intervention group was 16.75 with a SD of 5.34 (range 8-24).  
There was no significant change in the control group between T1 and T2 (mean change 
1 point, SD=3.16, p=0.30).There was a significant change in the intervention group on 
the Brief BESTest between T1 and T2 (mean change 2 points, SD=2.92, p=0.04). This 
indicated there was a statistically significant change in balance score between T1 and 
T2 for the intervention group. 
An independent T Test was computed to determine if there was a significant difference 
in the change in mean scores from T1 to T2 in the two groups. The difference between 
the groups was 1.0 (95% CI,-1.58, 3.58) indicating the Brief BESTest score of the 
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intervention improved more than that of the control group. The difference was not 
significant p=0.43. Figure 3.5 describes scores at T1 and T2 by group. 
 
 
 
Figure 3. 5 Brief BESTest scores at T1 and T2 in Control and Intervention Groups 
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3.5.2 Secondary Outcome measures 
3.5.2.1 Impairment: MDS-UPDRS 
 
The MDS-UPDRS is a rating scale that measures the longitudinal course of PD 
symptoms. Part two measures self-reported motor experiences of daily living and 
consists of 13 items. Part three measures motor examination and consists of 18 items. 
The mean score for the MDS-UPDRS part 2 for the control group was 11.42 with a SD 
of 9.27 (range 1-32). The mean score of the intervention group was 7.25 with a SD of 
3.96 (range 1-16). The mean change in the control group between T1 and T2 was 0.67 
with a SD of 2.19 and a p value of 0.31. The mean change in the intervention was 3.58 
with a SD of 3.75 and a p value of 0.007. This indicates there was a statistically 
significant improvement in self-reported motor experiences of daily living. Figure 3.6 
displays MDS-UPDRS scores at T1 and T2 by group. 
 
Figure 3.6 MDS-UPDRS Part Two scores at T1 and T2  
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The mean score for the MDS-UPDRS part 3 for the control group at T2 was 22.17 with 
a SD of 9.70 (range 7-34) and the mean score for the intervention group was 19.75 with 
a SD of 10.9 (range 9-43). The mean change in the control group was 2.42 with a SD of 
6.95 and a p value of 0.25. The mean change in the intervention group was -0.33 with 
SD of 10.67 and a p value of 0.92. An independent T Test was computed to determine 
the difference in the change in mean scores between groups. The difference between the 
groups in respect to motor experiences of daily living was -2.92 (95% CI -5.52,-0.32) 
indicating the motor experiences of daily living score of the intervention improved more 
than that of the control group. The difference was significant at p=0.03. There was no 
significant difference between groups in respect to motor examination, difference was -
2.92 (95% CI -5.52,-0.32,) p value 0.46. 
 
Figure 3.7 MDS-UPDRS Part Three scores at T1 and T2 
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3.5.2.2 Activity Limitations  
 
Timed up and Go test 
Three versions of TUG were included in this study. The standard TUG, the cognitive 
TUG (TUG-C) and the manual TUG (TUG-M).The mean TUG in seconds for the 
control at T2 was 13.75 with a SD of 8.61 (range 7-37). The mean TUG for the 
intervention group at T2 was 11.75 with a SD of 4.86 (range 8-22).The mean change in 
the control group between T1 and T2 was -0.75 with a SD of 1.17 and a p value of 
0.16.The mean change in the intervention group between T1 and T2 was -1.67 SD 4.96  
and a p value of 0.27. The difference in the change in mean scores from T1 to T2 
between groups was computed using an Independent T Test. The difference in respect to 
TUG was -0.92 (95% C1, 4.06,2.23) in favour of the intervention group with a  p value 
of 0.55 
 
Figure 3.8 TUG scores at T1 and T2 
48 
 
The mean TUG-C in seconds for the control at T2 was 19.25 with a SD of 15.25 (range 
8-52). The mean TUG for the intervention group at T2 was 15.75 with a SD of 8.23 
(range 10-40). 
An independent T Test compared the TUG between groups at T2. The mean difference 
was 3.31 seconds in favour of the intervention group with a 95% CI (-14.21, 7.21) and a 
p value of 0.51.  
The mean change in the control group between T1 and T2 was -0.42 with a SD of 6.67 
and a p value of 0.83  .The mean change in the intervention group between T1 and T2 
was -0.25 SD 4.67  and a p value of 0.86. 
The difference in the change in the score for the TUG-C was -0.17,95%CI (-4.71,5.04) 
in favour of the control group with a p value of 0.94. 
 
Figure 3.9 TUG-C scores at T1 and T2 
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The mean TUG-M in seconds for the control at T2 was 14.75 with a SD of 11.27 (range 
8-48). The mean TUG-M for the intervention group at T2 was 12.58 with a SD of 5.10 
(range 8-26).The mean change in the control group between T1 and T2 was -1.83 with a 
SD of 3.80 and a p value of 0.12 .The mean change in the intervention group between 
T1 and T2 was -2.67  SD 5.10  and a p value of 0.10 . 
 An independent T Test compared the TUG-M between groups at T2. The mean 
difference was -2.17 seconds in favour of the intervention group with a 95% CI (-
9.58,3.57 )   and a p value of 0.55. There was no significant difference in the change in 
mean scores between groups. The change score was -0.83(95% CI-4.65,2.98) with a p-
value of 0.66 
 
 
Figure 3.10 TUG-M scores at T1 and T2 
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Summary of outcome measures at T2 
Table 3.6 displays the change in mean scores between groups from t1 to T2 and the 
subsequent p-values and 95% Confidence Interval of the difference in scores. 
Table 3.6 Change in score between groups T1 to T2 
Outcome  
measures 
Mean (SD) change scores from 
T1-T2 
CI 
(95% of difference 
between groups ) 
P value 
Control Intervention 
Brief BESTest 1 (3.16) 2 (2.92) 1.58,3.58 0.43 
MDS-UPDRS 
2 
-0.67 (2.19) -3.58 (3.75) -5.52,-0.32 0.03 
MDS-UPDRS 
3 
-2.42 (6.95) 0.33 (10.67) -4.87,10.37 0.47 
TUG -0.75 (1.71) -1.67 (4.96) -4.06,2.23 0.55 
TUG-C -0.42 (6.67) -0.25 (4.67) -4.71,5.04 0.94 
TUG-M -1.83 (3.80) -2.67 (5.10) -4.65,2.98 0.66 
FES 
 
0.75 ( 5.12) 1.42  (6.42) -4.25,5.58 0.78 
Brief BEST: Brief BESTest, MDS-UPDRS: Movement Disorder Society Unified 
Parkinsons Disease Rating Scale, TUG: Timed Up and Go, TUG-C: Timed up and Go 
Cognitive, TUG-M: Timed Up and Go Manual,FES: Falls Efficacy Scale 
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3.5.2.4  The PDQ-39  
 
There only significant difference in the change in mean scores between groups was 
cognition in the control group (p=0.02). Table 3.7 displays the subsections. The PDSI 
increased in both groups but this was not statistically significant. 
Table 3.7 Change in sores of PDQ-39 between groups T1 to T2 
 Mean (SD) change in scores T1-
T2 
CI 
(95% of difference 
between groups ) 
P value 
Control Intervention 
Mob -3.5 (11.94) -3.(10.36) -8.96,9.96 0.91 
ADL -0.28 (7.58) 1.67 (11.06) -6.08,9.97 0.62 
Emot -2.5 (7.27) 3.05 (12.1) -2.89,14.0 0.19 
S 0.00 (5.22) 5.00 (15.08) -4.55,14.55 0.289 
SS 1.67 (7.18) -1.39 (16.71) -13.65,7.54 0.56 
Cog -2.5 (6.9) 7.08 (11.17) 1.72,17.45 0.02 
Comm 7.22 (19.79) 16.7 (8.59) -18.47,7.35 0.38 
BD 5.83 (12.88) 4.45(12.17) -12, 9.22 0.79 
PDSI 1.37 (6.40) 2.72 (7.6) -4.59, 7.30 0.64 
Mob: Mobility, ADL: Activities of Daily Living, EMOT: Emotions, S: Stigma, SS: Social Support, 
Cog: Cognition, Comm: Communication, BD: Body Discomfort, PDSI: Parkinson’s Disease Summary 
Index  
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3.5.2.5 Falls Efficacy Scale 
 
The Falls Efficacy Scale has a maximum score of 64. The mean score for the control 
group at T2 was 27.25 with a SD of 7.41 (range 16-41). The mean score for the 
intervention group at T2 was 27.42 with a SD of 10.15 (range 18-45). The mean change 
in the control group from T1 to T2 was 0.75 with a SD of 5.12, therefore indicating a 
worse score, not statistically significant with a p-value of 0.62.The mean change in the 
intervention group was 1.42 with a SD of 6.42, similarly indicating an increase in fear 
of falling, did not reach statistical significance with a p value of 0.46.The difference in 
the change in mean scores between groups was not significant (p value of 0.7). 
 
Figure 3.11 FES scores at T1 and T2 
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3.5.2.6 Falls during study     
 
The mean number of falls during the study for the control group was 0.25, SD 0.62 
(range 0-2). The mean number of falls for the intervention group was 0.42 with a SD of 
.996 (range 0-3). Falls were recorded via monthly falls calendars that were collected at 
T2. Twenty participants attended at T2 for reassessment, ten returned the falls 
calendars, seven from the intervention group. The remaining ten participants did not 
return the calendars but verbally reported they had had no falls. The difference in falls 
rate in the six months prior to the study and during the study was not significant. 
 
3.6 Summary of findings 
 
 Statistically significant difference in change in mean scores between groups at 
T1 and T2 for motor experiences of daily living as measured by part two MDS-
UPDRS. 
 Non- significant change in balance as measured by the Brief BESTest between 
groups. Statistically significant change in balance within group in the 
intervention group. 
 Non-significant change in TUG standard, cognitive and manual between groups. 
 Non-significant change in FOF and HRQOL between groups. 
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CHAPTER 4 DISCUSSION 
 
4.1 Statement of principal findings  
The aim of the study was to determine the effects of a six week balance exercise class 
on activity limitations in people with idiopathic Parkinson’s when compared to no 
intervention. Twenty four community dwelling PwPD were randomised to either the 
intervention or the control group. The intervention consisted of a programme of balance 
exercises for one hour weekly for six weeks in the physiotherapy gym in an acute 
teaching hospital. Blinded outcome assessors assessed participants at baseline and 
following the six week intervention. Participation in this intervention did not lead to a 
statistically significant change in balance. The intervention group had statistically 
significant improvement in self-reported motor influence on daily living measured by 
part two of the Movement Disorders Society-Unified Parkinson’s Disease Rating Scale 
(MDS-UPDRS). There was no significant change in the other secondary measures of 
falls, functional mobility, fear of falling and QOL.  
4.2 Results in the context of the current literature 
 
4.2.1 Balance 
 
The primary objective was to compare the change in balance measures between those 
participating in the balance exercise class and the control group. When the data was 
analysed there was no significant between group difference in the Brief BESTtest when 
comparing the two groups (p=0.43). However, there was a statistically significant 
improvement in balance score in the intervention group following the exercise class 
(p=0.04). 
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Duncan et al (2013) derived normative data for the Brief BESTtest in a population of 80 
subjects with PD. In a prospective cohort study the balance of the participants was 
measured using the BESTtest and the relationship between that score and the mini-
BEST and Brief BESTest was derived.  The accuracy of the Brief-BEST versus the 
other versions in identifying recurrent fallers in this population was compared. The 
mean Brief BESTest score was 13.2 (SD 5.5) (Duncan et al 2013). In this study the 
mean Brief-BESTest was 15.83 and 16.75 respectively for the control and intervention 
groups. In addition the mean score of the motor examination section of the MDS-
UPDRS was lower in this study.  This indicated that the sample in this study had higher 
balance scores and less disability than those in the Duncan et al (2013) study. This may 
reflect the difference in population that are referred to and attend the Physiotherapy 
service in an acute teaching hospital in comparison to those attending a movement 
disorder clinic. 
The optimal frequency and intensity of interventions in physiotherapy studies is 
unknown. Disparities are evident throughout the literature regarding optimal dosage. In 
this study the time frame of six weeks for a class intervention reflects a pragmatic 
approach to exercise delivery in the context of current clinical practice within this 
hospital setting.  The balance exercise programme consisted of standing on unstable 
surfaces, narrowing base of support and the addition of dual tasks. In addition the main 
author was limited by the time frame within which to complete this study due to the 
requirements of the research programme. An intervention of one hour per week for six 
weeks may not be of sufficient intensity to achieve a  
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clinical or significant change in balance in this patient group. Other authors have 
demonstrated favourable improvements with a more frequent intervention as described 
below. 
Smania et al (2010) in a RCT investigated the effect of balance training versus control 
exercise in 64 PwPD where the primary outcome was falls and balance as measured by 
the Berg Balance Score (BBS). Participants had a Hoehn and Yahr score of 3-4 
indicating postural instability on the pull test and were more severely affected than the 
population in this study. Intervention consisted of 21 treatment sessions of 50 minutes 
duration, three days per week for seven consecutive weeks. The authors describe in 
detail the balance programme to include feed forward and feedback mechanisms. In 
comparison, the control group carried out stretching, motor coordination and active joint 
mobilisation exercises. The control group’s exercise programme was not focused on 
improving postural reactions. The difference was significant in the primary outcome 
measures between the experimental and control groups before and after the study 
(p=0.00) and also when comparing scores before and one month follow-up (p=0.000).   
Both groups attended for three sessions weekly for seven weeks, this is a higher 
frequency than the current study and may explain the significant improvement. 
Gobbi et al (2009) in a study of 34 participants with PD, Hoehn and Yahr 1-3 assessed 
balance and mobility in two groups.  The first group received an intensive exercise 
programme for six months and the second a flexibility programme. The first group had 
three sessions per week the second only one, duration of intervention was six months 
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for both groups. Balance improved in both groups but not statistically significantly 
different between groups (p>0.05).  
A pragmatic RCT (n=130) by Goodwin et al (2011) consisted of a 10 week programme 
of balance and strength exercise, supplemented by a home exercise programme. A 
significant improvement in the secondary outcome measure of balance as measured by 
the BBS (p<0.01) post intervention and at 10 week follow up was evident .The 
inclusion criteria stipulated two or more falls in the previous year in comparison to the 
current study where 20.83% of the sample size had two or more falls in the previous six 
months. The addition of home exercise programme carried out twice a week in 
conjunction with ten weekly exercise groups in comparison to the current study, may 
have accounted for the improvement in balance score.  A limitation of this study was 
that the authors did not achieve the sample size of 92 per group that statistical analysis 
deemed necessary to power the study to 80%. 
In a small study with five participants Conradsson et al (2014) evaluated the feasibility 
of a highly challenging balance programme in PwPD. The severity of PD as measured 
by the Hoehn and Yahr scale was 2.6. The miniBEST test was utilised as the balance 
measure and although the sample size (n=5) was too small to determine effectiveness, 
four out of five participants improved on the outcome measures. There was no control 
group and the small sample size deems it difficult to generalise to the population. The 
mini Best test is also derived from the BEST test. 
Hirsh et al (2003) in a RCT compared two exercise programmes in a sample of 15 
PwPD. The first intervention included balance intervention alone and the second 
contained an additional strength component. The balance intervention was carried out 
over a 10 week period and exercises were performed three times a week. The balance 
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intervention consisted of exercises for the frail elderly and not specifically for 
impairments related to PD. The resistance component occurred for 15 minutes, three 
times a week and was based on a training programme that involved standard 
rehabilitation principles of progressive resistance training. The primary balance 
outcome measure consisted of a Sensory Organisation Test (SOT) on the EquiTest. 
Balance improved in both groups but to a larger degree in the group that received both 
balance and strength intervention. 
The majority of studies evaluating the effects of physiotherapy on Parkinson’s disease 
are conducted in hospital outpatient departments. Frazzitta et al (2013) investigated the 
effect of intensive rehabilitation on balance and gait with a one year follow up in an in-
patient setting. Intervention included stretches, balance exercises on a stabilometric 
platform and treadmill training over three sessions lasting and hour, five days a week 
for four weeks. Improvements in the BBS and UPDRS balance scores occurred and 
were maintained at one year follow up (p=0.001 ).  
4.2.2 Fall Rates 
 
In addition to the hypothesis that participation in this balance programme would 
improve balance, the author proposed that it would reduce the rate of falls. Falls history 
in the previous six months was obtained at baseline assessment. Eighteen participants 
(75%) reported that they had no history of falls in the six months prior to the 
commencement of the study. In comparison to other studies the history of one or more 
falls is an inclusion criterion. This reflects the mild to moderate severity of Parkinson’s 
symptoms in this sample. The cut off for falls in the brief BESTest was a score of less 
than 11 (Duncan et al 2013) and this is replicated in the current study. The 75% of the 
sample size that had no history of falls had a score greater than 11.There was no 
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difference in falls between groups in the study. Compliance with falls dairies was poor 
with ten participants (50% of those assessed at T2) returning the diaries. In addition the 
rate of falls in the study population was low, 25% of the sample had a fall or repeated 
fall in the previous six months. It was therefore unlikely that change in rate of falls over 
this period of time would occur. 
There is a lack of evidence in the literature regarding the ability of exercise and 
physiotherapy interventions to reduce the rate of falls. The rates and risk of falls have 
not been routinely utilised as outcome measures. In a study of similar duration to this 
authors i.e. six weeks, Ashburn et al (2007) in a RCT compared a home based exercise  
programme versus usual care where falls rate at eight weeks and six months was the 
primary outcome. The intervention included balance, strength, range of motion and  
walking. Following the intervention the participants received a phone call once a month 
from one of the treating researchers. The intervention group displayed lower falls rates 
at both time periods, and statistically significant reduction in near falls at eight weeks 
(p=0.004) and six months (p=0.007).The addition of a home exercise programme and  
the phone call may have had a positive effect on adherence to exercise and physical 
activity. 
Allen et al (2010) reported a 7% reduction in the falls risk score in the intervention 
group of a RCT. The intervention consisted of a 40 to 60 minute progressive strength 
and balance exercise programme, three times a week for six months. The participants 
attended a monthly exercise class and performed the remaining sessions at home The 
intervention group performed better in the secondary outcomes of interest. Falls risk 
score was the primary outcome and the difference was not significant (p=0.26).  
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Cueing training is increasingly incorporated into exercise programmes for people with 
PD. Nieubower et al (2007) in a randomised crossover trial with 153 participants, stage 
2-4 H&Y found improvements in fall rates for both the intervention and control groups 
but were not significant and not maintained at six week follow up. Elements in the 
intervention including walking while dual tasking and walking on variable surfaces 
were similar to this study.  
The results of this study on falls rates may be interpreted with caution. The participants 
in this study had a low history of falls. The duration of the study and follow up period 
was limited by time constraints.  It would have been desirable to have follow-up over a 
period of longer duration.  
4.2.3. Disease severity scale 
 
The MDS-UPDRS was administered to determine change in disease severity. Part two 
measures self- reported motor experiences of daily living (ADL) and section three 
measures motor examination.   
Goetz et al (2008) described normative data in 80 PwPD: section two mean 16.0(SD 
10), section three mean 36.8 (SD 18.4). In the current study the mean score at baseline 
for the sample was 11.46 (SD 7.45) and part three 22 (SD 9.97) indicating milder 
symptoms in this population. 
There was a statistically significant improvement in motor experiences of daily living 
for the intervention group (p=0.007) pre and post intervention. In addition when 
comparing the change in mean scores between groups, there was a statistically 
significant improvement in the intervention group (p=0.03). The change in the motor 
score was not significant within the groups or when comparing the change scores 
between groups. 
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In a Cochrane review of 39 RCTs (n=1379) there was significant improvement in the 
ADL (157 participants, p=0.01) and motor section (431 participants, p=0.00001). There 
was no evidence of heterogeneity between the individual trials, nor was there any 
evidence of heterogeneity between the different types of physiotherapy intervention. 
In the study by Ellis (2005) where participants received physiotherapy  ( 12 sessions, 
one and a half hours in duration, twice a week for six weeks) and medication for six 
weeks there was a significant improvement in ADL (p=0.015) but not in the motor 
section. 
In the study by Schenkman et al (2012) of three types of intervention including 
flexibility/balance/function (FBF), supervised aerobic exercise (AE) and a home based 
exercise programme (control), the authors hypothesised there would be a difference in  
symptom severity as measured by UPDRS. Similarly in our study there was significant 
improvement in the ADL section but not the motor section.  
The sample of the current study was a heterogeneous sample with wide range in scores 
at both baseline and post intervention. In addition, measuring change is limited in such a 
short time period. 
4.2.4 Functional mobility 
 
Functional mobility was measured by the Timed Up and Go (TUG), Timed Up and Go- 
Cognitive (TUG-cognitive) and Timed Up and Go-Manual (TUG-manual). 
There was no significant difference between groups. However the TUG and TUG 
manual –demonstrated trends towards improvement in the intervention group. Huang et 
al (2011) reported that the minimal detectable change in the TUG in a PD population is 
11.8 seconds; this was not achieved in either group.  Huang et al (2011) derived this 
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figure from a convenience sample of 72 PwPD from a movement disorder clinic and the 
mean age was 67.5 years.  
Allen et al (2011) conducted a systematic review and meta-analysis on the effects on 
exercise on balance and falls in PD. The authors reported that while there were 
favourable trends in the TUG in favour of the intervention, it did not reach statistical 
significance. Nieuwboer et al (2007) reported a trend toward improvement in TUG but 
it was not statistically significant (p=0.6) at follow up. Gobbi et al (2009) did not find 
significant difference for mobility as measured by the TUG between groups (p>0.05). 
 
4.2.5 Confidence and participation 
 
The Falls Efficacy Scale (FES) measured fear of falling in this study. The mean (SD) 
score for the control group post intervention was 27.25 (7.41) and for the intervention 
group was 27.42(10.15). When considering cut offs for concern of fear of falling, based 
on a longitudinal validation study by Delbaere et al (2010) both groups lie just outside 
the moderate range (22-27). The difference in change of mean scores between groups 
was not significant (p=0.78).  
Tomlinson et al (2012) in a systematic review of physiotherapy in a PD population 
versus placebo or no intervention assessed the impact of fear of falling.  Four trials 
consisting of 353 participants had data on the FES. Two of the trials were exercise and 
the others involved cueing strategies. In the trial by Nieubouer et al (2007) the 
improvements in rates of falls were not statistically significant. Allen et al’s (2010) 
study was included in this systematic review and reported a non-significant trend 
towards improvement in FES following a strength and balance intervention. 
Improvement in balance may not translate to an improvement in fear of falling. There 
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was no difference in FES between two groups in the systematic review (p=0.19). 
Questioning participants specifically regarding their fear of falling may heighten their 
awareness of it. Nilsson et al (2012) reported that fear of falling is associated with 
multiple factors including walking capacity, freezing, assistance with ADLs and fatigue.  
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4.2.6 Quality of Life 
 
A six week balance exercise class was found not to have a significant positive influence 
on QOL as measured by the PDQ-39.A trend towards improvement was noted in both 
groups for the mobility subsection at T2 but this was not statistically significant 
(p=0.92). In addition a trend towards improvement in social support section was noted 
in the intervention group and the ADL section of the control group. 
The difference in the mean change in the index score was not significant for either 
group in this study (p=0.64). There was a non-significant increase in the score 
indicating a reduction in health related quality of life (HRQOL).No improvement was 
found between the groups on the PDQ-39 following the intervention. The findings in 
this study are similar to other studies where QOL did not improve statistically when 
compared to no intervention (Tomlinson et al 2012). It is worth noting that the ADL 
section of MDS-UPDRS improved, in comparison to the mobility section of the PDQ-
39. These measures differ as the latter is a self-reported measure and the former was 
interviewed by the assessor. 
Allen et al (2010) did not find a significant difference in QOL as measured by the PDQ-
39. Goodwin et al (2008) reported an improvement in QOL linked to improvement in 
mobility. In the current study there was no significant change in balance or functional 
mobility therefore the participants’ perception of QOL remained unchanged. 
 
4.3 Strengths of the study  
 
This study was a pragmatic RCT that compared an exercise intervention against a 
control group. The sample consisted of a heterogenous population and is reflective of 
clinical practice in an acute Dublin teaching hospital. The outcome measures were 
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validated in this population and assessed across ICF classifications of impairment, 
activity and participation measures. Bias was minimised since assessors were blinded to 
group participation. Increasing numbers of studies are demonstrating favourable 
outcomes for physiotherapy, this study adds to that body of work. 
4.4 Limitations in the study  
 
 This study had a small sample size and was not powered to detect changes in 
secondary outcome measures.  
 The study was of short duration and intensity. The literature has demonstrated 
more favourable outcomes in balance and falls with a longer duration and 
increase intensity of interventions.  
 The sample had mild to moderate PD therefore cannot be generalisable to all 
stages of PD  
 Changes in medications during the course of the study were not accounted for. 
 It was not feasible to ensure all participants exercised at peak ‘on’ dose.  
 The assessors were formally trained in the MDS-UPDRS 
 
4.5 Clinical/ Policy implications 
 
 Longer duration studies are warranted 
 Supplement intervention with HEP 
 Incorporate a strength component may have achieved more favourable outcomes 
 Incorporate a falls prevention component 
 Earlier referral to PT services as a large proportion of PwPD are not referred 
until later stages. 
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4.6 Areas for future research 
 
 Longer study duration, intensity and follow up. 
 Larger sample size (multi-centre) 
 Explore cognitive  task training further  
 Adherence to exercise and physical activity over a longer term 
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CONCLUSION 
 
This study was a randomised controlled trial and achieved its sample size based on 
statistical analysis of the primary outcome measure. The study demonstrated significant 
change in the intervention group for ADL section of clinical disease rating scale, non-
significant change in balance between groups, and no change in FOF or HROL. 
The sample population were all referred for physiotherapy to an out-patient 
physiotherapy department. Inclusion criteria deemed that they be independently mobile 
with and without an aid. The sample had a low rate of falls and baseline measures on 
balance and disease severity scale were higher than normative values for this 
population, indicating less disease disability. The duration and intensity of the 
intervention reflects current clinical practice, but may not be enough to warrant a 
change in balance scores. Postural instability is one of the cardinal features of PD and 
may be difficult to treat optimally with pharmacology. Postural instability and reduced 
balance lead to falls, reduced mobility and increased disability. Increasing evidence 
points to the effectives of physiotherapy interventions for improving balance. Other 
studies have demonstrated more favourable outcomes with addition of strength training 
and higher frequency of intervention. This study was not powered to detect change in 
the secondary outcome measures. There was no significant change in fear of falling or 
HRQOL. This may reflect the short duration and lack of change in the primary 
measures. Further research in this area is required with larger sample sizes and longer 
follow up. 
Word Count : 11604 
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Appendix 1  
Letter of Invitation to Study Participant’s       
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Appendix 2 Patient Information Leaflet     
   
 
       
   
 
Patient Information  Leaflet 
 
 
1. Title of study: The effect of a balance exercise class on activity limitations in people 
with Parkinson’s disease. 
 
2. Introduction: The Physiotherapy Department is investigating how a 6 week balance 
exercise class will affect balance, activity and quality of life in a sample of community 
dwelling people with Parkinson’s disease (PD) in comparison to no class. You have 
equal chance of being in either group. If you are in the group that does not receive the 
class you will be offered the class after the study period. 
 
3. Procedures: If you chose to participate you will be asked questions regarding length of 
time of diagnosis, the medication you are taking, if you have had any falls and if you 
had any recent Physiotherapy. We will assess your balance, confidence carrying out 
tasks and walking .The balance exercise class will take place in the physiotherapy 
department. The class will run once a week for 6 weeks and last an hour. 
 
4. The study may help to improve your balance and your confidence doing day to day 
tasks and reduce future falls. 
 
5. There is a very small risk you may lose your balance and fall during the study. However 
this is unlikely and you will be supervised at all times by a physiotherapist. 
 
6. You are invited to participate due to your diagnosis of Parkinson’s. If you agree to 
participate a member of Physiotherapy staff will telephone you and ask a few screening 
questions to determine if you are eligible. 
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7. Exclusion from participation: Your doctor has told you that you cannot be in this 
study if any of the following are true: If you have an orthopaedic or cardiovascular 
condition that limits your ability to participate in the treatment. If you are unable to give 
informed consent. 
 
 
8. Alternative treatment: the study will not interfere with your hospital treatment. 
 
9. Confidentiality: 
Your identity will remain confidential. Your name will not be published and will not be 
disclosed to anyone outside the hospital. 
 
10. Compensation: 
The researchers and Physiotherapists in the study are covered by standard medical 
malpractice insurance. Nothing in this document restricts or curtails your rights. 
 
11. Voluntary Participation: You have volunteered to participate in this study. You may 
quit at any time. If you decide not to participate, or if you quit, the routine management of 
your PD condition will not be affected in any way. 
12.  Permission: Ethical approval for this study has been granted by the SJH/Tallaght 
hospital Research Ethics Committee. 
 
13. Further information: You can get more information or answers to your questions 
about the study, your participation in the study, and your rights, from Anne Belton who can 
be telephoned at 014142750. 
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Appendix 3  Consent Form 
 
       
 
Title of research study: The effect of a balance exercise class on activity limitations in people 
with Parkinson’s disease. 
This study and this consent form have been explained to me. The physiotherapist has 
answered all my questions to my satisfaction. I believe I understand what will happen if I agree 
to be part of this study. 
I have read, or had read to me, this consent form. ⁪ 
I have had the opportunity to ask questions and all my questions have been answered to my 
satisfaction ⁪ 
I freely and voluntarily agree to be part of this research study, though without prejudice to my 
legal and ethical rights. ⁪ 
I have received a copy of this agreement. ⁪ 
PARTICIPANT’S NAME: 
PARTICIPANT’S SIGNATURE:  
Date: 
Date on which the participant was first furnished with this form: 
Where the participant is incapable of comprehending the nature, significance and scope of the 
consent required, the form must be signed by a person competent to give consent to his or her 
participation in the research study (other than a person who applied to undertake or conduct 
the  
 
study). If the subject is a minor (under 18 years old) the signature of parent or guardian must 
be obtained: 
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NAME OF CONSENTOR, PARENT or GUARDIAN: 
SIGNATURE: 
 
RELATION TO PARTICIPANT: 
 
Where the participant is capable of comprehending the nature, significance and scope of the 
consent required, but is physically unable to sign written consent, signatures of two witnesses 
present when consent was given by the participant to a registered medical practitioner 
treating him or her for the illness. 
 
NAME OF FIRST WITNESS:   SIGNATURE: 
NAME OF SECOND WITNESS:   SIGNATURE: 
 
 
Physiotherapist’s signature: 
 
Date 
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Appendix 4 
Hoehn and Yahr Scale 
The Hoehn and Yahr scale is a commonly used 
system for describing how the symptoms of 
Parkinson’s disease progress. 
 
Hoehn and Yahr Scale 
Classified disease into 6 stages 
0 = No clinical signs evident 
1 =  Unilateral involvement only 
2 =  Bilateral involvement only 
3 =  First evidence of postural and righting 
reflexes by examination or a history of poor balance, 
falls 
4 =  Fully developed sever disease, disability 
marked 
5 =  Confinement to bed or wheelchair 
Reference: 
Hoehn M, Yahr M (1967) Parkinsonism: onset, progression and mortality.  
Neurology 17(5): 427 – 442. 
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Appendix 5 
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Appendix 6 Ethics Letter 
 
76 
 
Appendix 7 Ethics form 
 
STANDARD APPLICATION FORM 
 
For the Ethical Review of 
Health-Related Research Studies, 
which are not Clinical Trials of 
Medicinal Products For Human Use  
as defined in S.I. 190/2004 
 
 
 
 
DO NOT COMPLETE THIS APPLICATION FORM 
 IF YOUR STUDY IS A CLINICAL TRIAL OF A MEDICINAL PRODUCT 
 
 
 
 
 
Title of Study:  The effect of a balance exercise class on activity limitations 
in people with Parkinson’s disease 
 
Principal Investigator: Anne Belton  
 
Applicant’s Signature:______________________________________ 
 
 
For Official Use Only – Date Stamp of Receipt by REC: 
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2 TABLE OF CONTENTS MANDATORY/OPTIONAL 
 
SECTION A GENERAL INFORMATION MANDATORY 
 
SECTION B STUDY DESCRIPTORS MANDATORY 
 
SECTION C STUDY PARTICIPANTS MANDATORY 
 
SECTION D RESEARCH PROCEDURES MANDATORY 
 
SECTION E DATA PROTECTION MANDATORY 
 
SECTION F HUMAN BIOLOGICAL MATERIAL OPTIONAL 
 
SECTION G RADIOCATIVE MATERIAL / DIAGNOSTIC OR  
THERAPEUTIC IONISING RADIATION OPTIONAL 
 
SECTION H MEDICAL DEVICES OPTIONAL 
 
SECTION I MEDICINAL PRODUCTS / COSMETICS / FOOD AND FOODSTUFFS OPTIONAL 
 
SECTION J INDEMNITY MANDATORY 
 
SECTION K COST AND RESOURCE IMPLICATIONS AND FUNDING MANDATORY 
 
SECTION I ETHICAL ISSUES MANDATORY 
 
 
 
This Application Form is divided into Sections. 
 
Sections A, B, C, D, E, J, K, L are Mandatory. 
 
Sections F, G, H, and I are optional.  Please delete Sections F, G, H, and I if 
these sections do not apply to the application being submitted for review. 
 
IMPORTANT NOTE:  Please refer to Section I within the form before any 
attempt to complete the Standard Application Form.  Section I is designed 
to assist applicants in ascertaining if their research study is in fact a clinical 
trial of a medicinal product. 
 
IMPORTANT NOTE:  This application form permits the applicant to delete individual questions 
within each section depending on their response to the preceding questions.  Please respond 
to each question carefully and refer to the accompanying Guidance Manual for more in-depth 
advice prior to deleting any question.  SECTION A  GENERAL INFORMATION  
 
SECTION A IS MANDATORY 
 
IMPORTANT NOTE:  This application form permits the applicant to delete 
individual questions within each section depending on their response to the 
preceding questions.  Please respond to each question carefully and refer to 
the accompanying Guidance Manual for more in-depth advice prior to 
deleting any question.   
 
 
A1 TITLE OF THE RESEARCH STUDY: 
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The effect of a balance exercise class on activity limitations in people with 
Parkinson’s disease 
 
A2  Principal Investigator(s):   
Title:  Ms. Name:  Anne Belton   
Qualification: BSc(Hons) Physiotherapy   
Position: SENIOR Physiotherapist   
Dept:       Physiotherapy      
Organisation:  Tallaght Hospital      
Address: Dublin 24        
TEL:  014142750 E-MAIL:anne.belton@amnch.ie   
 
A3 (a) Is this a multi-site study?     No   
 
A3 (b) Please name each site where this study is proposed to take 
place and state the lead investigator for each site: 
 
Site: Lead Investigator: 
PHYSIOTHERAPY DEPARTMENT  
TALLAGHT HOSPITAL 
DUBLIN 24 
ANNE BELTON 
SENIOR PHYSIOTHERAPIST 
 
A3 (C) FOR ANY OF THE SITES LISTED ABOVE, HAVE YOU GOT AN 
OUTCOME FROM THE RESEARCH ETHICS COMMITTEE (WHERE 
APPLICABLE)? 
  
No 
 
 
A4.  CO-INVESTIGATORS: 
 
NAME OF SITE     
 
Royal College of Surgeons in Ireland 
 
Title: Dr. Name:   ROSE GALVIN 
QUALIFICATIONS:  PHD 
POSITION:  LECTURER IN PHYSIOTHERAPY 
ORGANISATION:  ROYAL COLLEGE OF SURGEONS IN IRELAND 
Address:  School of Physiotherapy, 123 St Stephens Green, Dublin 2
  
ROLE IN RESEARCH:  Supervisor   
 
A4.  CO-INVESTIGATORS: 
 
NAME OF SITE     
 
Tallaght Hospital 
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Title: DR Name: Richard Walsh 
QUALIFICATIONS:  MD MRCPI 
POSITION:  CONSULTANT NEUROLOGIST 
ORGANISATION:  TALLAGHT HOSPITAL 
Address: Dublin 24 
ROLE IN RESEARCH: Co-Investigator 
 
A4.  CO-INVESTIGATORS: 
 
NAME OF SITE     
 
Tallaght Hospital 
 
Title:  Name: Dr Dominick McCabe 
QUALIFICATIONS:  PHD, FRCPI  
POSITION:  Consultant Neurologist/Clinical Associate Professor in 
Neurology/Honorary Senior Lecturer in Clinical Neurosciences/Co-
Director of the Rapid Access Stroke Prevention Service            
ORGANISATION:  Tallaght Hospital 
Address:  Dublin 24  
ROLE IN RESEARCH: CO-INVESTIGATOR 
 
.  CO-INVESTIGATORS: 
 
NAME OF SITE     
 
Tallaght Hospital 
 
Title:  Name Dr Sinead Murphy 
QUALIFICATIONS:  MB BCH MD MRCPI 
POSITION:  CONSULTANT NEUROLOGIST 
ORGANISATION:  TALLAGHT HOSPITAL 
Address:  Dublin 24  
ROLE IN RESEARCH: CO-INVESTIGATOR 
 
 
 
A5.  Lead contact person who is to receive correspondence in 
relation to this application or be contacted with queries about 
this application.  
 
Title: Ms. Name:   ANNE BELTON 
Address:  PHYSIOTHERAPY DEPARTMENT, TALLAGHT HODPITAL 
TEL (WORK): 014142750 TEL (MOB.):   
E-MAIL: ANNE.BELTON@AMNCH.IE 
  
 
A6.   Please provide a lay description of the study.  
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The aim of the study is to assess the impact of a balance exercise class in 
people with Parkinson’s disease (PD). Postural instability is one of the main 
symptoms of PD and can causes reduced balance and can this can lead to 
falls. People with PD have a higher rate of falls than the general population. 
Reduced balance and falls can cause serious injury, including fracture and 
hospitalisation. Reduced balance and fear of falling can impact on activity 
and day to day life. Balance and postural stability are also influenced when 
doing more than one task at the same time. It can be difficult to maintain 
balance when doing more than one task for people with PD. Exercise and 
physical activity can improve balance and may reduce falls; it is not known 
which type of exercise is of most benefit. The aim is to assess the effect of a 
balance class, including tasks doing more than one at a time on balance, 
confidence and day to day activity. 
 
A7 (A) IS THIS STUDY BEING UNDERTAKEN AS PART OF AN 
ACADEMIC QUALIFICATION? Yes    
 
A7 (b) IF YES, please complete the following: 
Student Name: Anne Belton  Course:  
Msc Physiotherapy (Neurology and Gerontology  
Institution: Royal College of Surgeons of Ireland
 Academic Supervisor: Dr Rose Galvin  
 
 
3 SECTION B STUDY DESCRIPTORS 
 
SECTION B IS MANDATORY 
 
B1.   Provide information on the study background.  
 
Parkinson’s disease (PD) is a chronic progressive neurological disorder characterised by tremor, 
rigidity, bradykinesia and postural instability. The number of people over 50 years in Westerns 
Europe’s five most populous nations who have PD was  estimated at between 4.1 and 4.6 
million in 2005 and is expected to double by 2030 (Dorsey et al 2007). 
Postural instability may occur at any stage of the disease and is associated with falls, poor 
mobility, disability and reduced quality of life (qol) (Allen et al 2011). Reduction in balance in 
addition to the impact on falls leads to reduction in activity. Allen et al (2013) in a systematic 
review of 22 studies reported that falls rates vary from 35-90% for a single fall and 18-65% for 
recurrent falls. Wielinski et al (2005) reported that 65% of those people who fall will 
experience an injury and 33% will sustain a fracture.   
The management of PD has centered on pharmacology intervention, but despite optimum 
management patients still experience a deterioration of body function, daily activities and 
participation (Nijkrate et al 2007). Pharmacological management to date has had little 
influence on postural instability in the latter stages of the disease (Kim et al 2013). 
 There is moderate evidence that physical activity and exercise can improve performance on 
measures of postural instability and balance related activity in people with mild to moderate 
Parkinson’s (Dibble 2009). However there is insufficient evidence to determine if improvement 
in balance translates to reduction in falls (Kim 2013). 
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Studies are limited by small sample sizes, the variety of interventions and inadequate follow up. There is 
no consensus on which type of intervention is the most efficacious (Cochrane 2012). There are few 
studies of balance on falls but there is a trend towards positive outcomes of balance measures in these 
studies. Highly challenging balance exercise programmes have improved balance and reduced falls in the 
elderly ( Sherrington 2008). Further studies are required to determine which interventions improve 
balance, postural instability, reduce falls and improve activity and participation. An increasing elderly 
population and an increase in numbers of people with PD will impact on the economy and health services. 
Therefore effective interventions are required to improve balance, reduce activity limitations and reduce 
disability in this population. 
This study will assess the impact of a balance class on activity limitation in people with PD, with 
a particular focus on balance. The author using the ICF WHO classification of disability will also 
accesses the impact of this intervention on impairment, activity and participation levels. 
 
 
 
B2.    List the study aims and objectives.   
 
Aim: To assess the effect of a balance exercise class on activity limitations 
in people with Parkinson’s disease when compared to a waitlist control 
group. 
Objectives: To determine if a 6 week balance exercise class will improve 
balance related measures, confidence, activity limitations and participation 
in people with PD 
 
B3.    List the study endpoints (if applicable).  
 
The primary outcome is to evaluate the effect of a balance exercise class on 
balance measures in people with Parkinson’s disease. 
 
B4.   Provide information on the study design. 
 
A single blinded randomised controlled trial 
 
 
B5.   Provide information on the study methodology. 
  
Study Design 
A single blinded randomised controlled trial will be conducted to ascertain the impact of a 
balance exercise class on community dwelling people with PD living in southwest Dublin .A 
control group will be used to determine the effectiveness of the intervention. This group will 
not receive any formal physiotherapy intervention and will be advised to continue activity as 
normal for the duration of the study. They will be offered the intervention on completion of 
the study. 
Subject recruitment 
The patients will be recruited from the physiotherapy department waiting list for out-patient 
physiotherapy and physiotherapy review database. Patients from the database may have 
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attended for physiotherapy intervention and a PD class in the past. However patients will be 
excluded if they have attended for physiotherapy at the Department in the previous three 
months,  
The participants will be contacted by a gatekeeper by telephone to determine if they wish to 
participate. Following a brief screening process to determine eligibility, participants will be 
asked if they would like to receive more information about the nature of the project. If they 
are willing to receive more information, an information pack containing a cover letter ( 
Appendix 1), participant information leaflet) (Appendix2 ) and consent form (appendix 3) will 
be sent to all interested PwPD . Participants will be contacted after one week to determine 
consent.  
Randomisation: 
To minimise the possibility of recruitment bias, a person independent of the recruitment 
process (AS) will complete random group allocation with consecutive individuals who have 
given written informed consent. With random assignment, the aim is to give all participants an 
equal chance of being assigned to either the experimental group or the control group. By 
assigning participants at random, it is possible to infer that any observed group differences are 
attributable to the independent variable. Computer generated random numbers will be 
created and placed in sealed envelopes by this independent person. These numbers will be 
stored in the pre-sealed envelopes in a locked drawer in the Department of Physiotherapy. 
Allocation will revealed after recruitment – following contact from the PI, the independent 
person (AS) will open the next envelope in the sequence and give the randomisation 
information to the PI. Each envelope will be opened on enrollment of an eligible participant. 
After allocation is revealed, the appropriate intervention/control will organised by the 
researcher.   
Inclusion Criteria: 
Participants will be included if they have a diagnosis of idiopathic Parkinson’s disease, 
diagnosed by a consultant Neurologist and are independently mobile with or without an aid. 
Stages 1-4 of the Hoehn and Yahr disease severity will be included.  
Subjects will be excluded if they have non-Idiopathic Parkinson’s disease, cardiovascular or 
orthopaedic conditions that limit mobility. Participants will be excluded if they score less than 
24 on MMSE and if they are unwilling or unable to provide written consent. Subjects will be 
excluded if they have attended for Physiotherapy in the department in the previous three 
months. 
Outcome measures 
All participants will be assessed by a blinded assessor at baseline and after the intervention, 
therefore limiting detection bias.  
Primary outcomes measure:  
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-Brief BESTest  (valid and reliable measure of balance and predictor of falls in the patient 
group) (Duncan et al 2012). 
Secondary OM  
Impairment 
UPDRS- Motor subsection – (Goetz et al 2008) 
Activity limitation 
Timed up and Go- Manual and Cognitive- measure of functional mobility, additional sections 
provide information on dual tasking (Campbell et al 2003) 
Participation restriction  
Parkinson’s disease Questionnaire 39 is a measure of QOL  
Falls Efficacy Scale- balance confidence with ADLs and is valid and reliable in this population 
(Peto et al 1995) 
Additional measures: 
A detailed falls history will be obtained and participant will keep a falls diary during the trial. 
Falls will be defined as ‘an unexpected event in which the participant comes to rest on the 
ground floor, or lower level’ (Morris 2011) Falls diary, near falls, circumstances and injuries  
Trail making test- measures ability to switch from one task to another  
 
B6.   What is the anticipated start date of this study? 
  
Sept 2nd 2013 
 
B7.   What is the anticipated duration of this study? 
  
9 months 
 
B8 (a) How many research participants are to be recruited in total? 
  
24   
 
B8 (b)   Provide information on the statistical approach to be used 
(if appropriate) / source of any statistical advice.   
 
Descriptive statistics will be used to describe baseline information. 
To determine if there is a significant difference in scores from baseline 
between the control and the intervention group a Mann Whitney test will be 
utilised. 
An independent two sample t-test (two tailed) will be computed for 
continuous data. All tests will be completed with a 0.05 level of significance. 
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B8 (c)  Please justify the proposed sample size and provide details 
of its calculation (including minimum clinically important 
difference).   
Based on the primary outcome measure the Brief BESTest a sample size of 
20 is required to detect a clinically meaningful difference between the 
groups set at 6 points at a two-sided significance level of 5% and a power 
of 80%. A sample size of 24 required to allow for attrition of 20% 
 
B8 (d)  Where sample size calculation is impossible (e.g. It is a pilot 
study and previous studies cannot be used to provide the required 
estimates) then please explain why the sample size to be used has 
been chosen.   
 
See above. 
 
 
 
4 SECTION C study PARTICIPANTS 
 
SECTION C IS MANDATORY 
 
IMPORTANT NOTE:  This application form permits the applicant to delete 
individual questions within each section depending on their response to the 
preceding questions.  Please respond to each question carefully and refer to 
the accompanying Guidance Manual for more in-depth advice prior to 
deleting any question.   
 
 
5 SECTION C1 PARTICIPANTS – SELECTION AND 
RECRUITMENT 
 
 
C1. 1 How many research participants are to be recruited?  At each 
site (if applicable)? And in each treatment group of the study (if 
applicable)?   
 
NAME OF SITE: NAMES OF TREATMENT GROUP (IF 
APPLICABLE) 
INSERT NAME 
OF GROUP: 
INTERVENTION 
INSERT 
NAME OF 
GROUP:  
CONTROL 
INSERT 
NAME OF 
GROUP:  
PHYSIOTHERAPY 
DEPARTMENT, 
TALLAGHT HOSPITAL 
 
12 
 
12 
 
(INSERT ROWS AS 
REQUIRED) 
   
 
C1.2  How will the participants in the study be selected?  
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The participants will be recruited from the physiotherapy department out-
patient waiting list and physiotherapy review database.  
 
 
 
C1.3  How will the participants in the study be recruited?   
The participants will be contact by a gatekeeper by telephone to determine if they wish to 
participate. Following a brief screening process to determine eligibility, participants will be 
asked if they would like to receive more information about the nature of the project. If they 
are willing to receive more information, an information pack containing a cover letter 
(Appendix 1), participant information leaflet) (Appendix2) and consent form (appendix 3) will 
be sent to all interested PwPD. Participants will be contacted after one week to determine 
consent.  
 
 
 
 
C1.4 What are the main inclusion criteria for research 
participants?  (please justify)  
 
Diagnosis of Idiopathic Parkinson’s by Consultant Neurologist. 
Hoehn and Yahr disease rating scale 1-4. 
Independently mobile with or without an aid. 
MMSE ≥24. 
 
C1.5 What are the main exclusion criteria for research 
participants?  (please justify) 
 
Non- Idiopathic Parkinson’s disease. 
Cardiovascular or orthopaedic conditions that limit mobility. 
Unable to give informed consent 
PT intervention in the department in the last 3 months 
 
C1.6 Will any participants recruited to this research study be 
simultaneously involved in any other research project?  
 No 
 
 
6 SECTION C2 PARTICIPANTS – INFORMED 
CONSENT 
 
 
C2.1 (a) Will informed consent be obtained?  Yes  
 
C2.1 (b) If no, please justify.   
 
Answer 
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C2.1 (c) If yes, how will informed consent be obtained and by 
whom? 
 
Potential participants will have receive an information pack containing a 
cover letter,  patient information leaflet and consent form for the 
gatekeeper. Potential participants will be contacted one week after they 
receive documentation to  determine consent. 
 
C2.1 (d) Will participants be informed of their right to refuse to 
participate and their right to withdraw from this research study? 
 
Participants will be informed that there is no obligation to participate 
and they may withdraw at any time in the study without affecting 
their care. The investigator will also be guided by her professional code of conduct as 
stipulated by Irish Society of Chartered Physiotherapists. 
 
 
C2.1 (f) Will there be a time interval between giving information 
and seeking consent? Yes  
 
 
C2.1 (g) If yes, please elaborate. 
   
Participants will be given at least 7 days to make a decision regarding 
participation 
 
7 SECTION C3 adult participants - CAPACITY 
 
 
C3.1 (a) Will all adult research participants have the capacity to 
give informed consent?  YES  
 
C3.1 (b) If no, please elaborate. 
  
 
C3.1 (c) If no, is this research of such a nature that it can only be 
carried out on adults without capacity?  Yes / No 
 
C3.1 (d) What arrangements are in place for research 
participants who may regain their capacity?   
 
Answer 
 
 
8 SECTION c4 participants under the age of 18 
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C4.1  (a) Will any research participants be under the age of 18 
i.e. Children?  
 No 
 
 
 
9 SECTION C5 PARTICIPANTS -  CHECKLIST  
 
Please confirm if any of the following groups will participate in this 
study.  This is a quick checklist for research ethics committee 
members and it is recognised that not all groups in this listing will 
automatically be vulnerable or lacking in capacity. 
 
C5.1 Patients  Yes  
C5.2 Unconscious patients   No 
C5.3 Current psychiatric in-patients No 
C5.4 Patients in an emergency medical setting No 
C5.5 Relatives / Carers of patients No 
C5.6 Healthy Volunteers No 
C5.7 Students No 
C5.8 Employees / staff members No 
C5.9 Prisoners No 
C5.10 Residents of nursing homes No   
C5.11 Pregnant women  No 
C5.12 Women of child bearing potential  No 
C5.13 Breastfeeding mothers No 
C5.14 Persons with an acquired brain injury  No 
C5.15 Intellectually impaired persons No 
C5.16 Persons aged > 65 years Yes  
 
C5.17 If yes to any of the above, what special arrangements have 
been made to deal with issues of consent and assent (if any)? 
   
Refer to C21 c 
 
 
10 SECTION D research  PROCEDURES 
 
SECTION D IS MANDATORY 
 
IMPORTANT NOTE:  This application form permits the applicant to delete 
individual questions within each section depending on their response to the 
preceding questions.  Please respond to each question carefully and refer to 
the accompanying Guidance Manual for more in-depth advice prior to 
deleting any question.   
 
 
D1.  WHAT RESEARCH PROCEDURES OR INTERVENTIONS (OVER 
AND ABOVE THOSE CLINICALLY INDICATED AND/OR OVER AND 
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ABOVE THOSE WHICH ARE PART OF ROUTINE CARE) WILL 
RESEARCH PARTICIPANTS UNDERGO WHILST PARTICIPATING IN 
THIS STUDY? 
 
Exercises classes for patients with Parkinson are run routinely in the 
Physiotherapy department and are part of routine care. This class will focus 
primarily on balance. 
 
D2.  If there are any potential harms resulting from any of the 
above listed procedures, provide details below: 
 
The participant will partake in a balance exercise class. Balance exercises 
are a routine component of Physiotherapy intervention. As with any balance 
exercise there is a risk of falls, however the participants will be supervised 
at all times and a risk assessment as per usual care. A risk assessment of 
the Physiotherapy gym will be carried out prior to each class as per usual 
care. 
 
D3.  What is the potential benefit that may occur as a result of 
this study?  
 
Participation in the class may improve balance related measure and improve  
confidence and activity and participation in activities of daily living 
 
D4 (A) WILL THE STUDY INVOLVE THE WITHHOLDING OF 
TREATMENT? 
NO  
 
D4 (B) WILL THERE BE ANY HARMS THAT COULD RESULT FROM 
WITHHOLDING TREATMENT?  NO 
 
D4 (C) IF YES, PLEASE ELABORATE. 
  
The control group will be offered the intervention post data collection period 
 
D5.  HOW WILL THE HEALTH OF PARTICIPANTS BE MONITORED 
DURING AND AFTER THE STUDY? 
 
The patients will be monitored as part of usual care by the therapists taking 
the class. 
 
 
D6 (A) WILL THE INTERVENTIONS PROVIDED DURING THE STUDY 
BE AVAILABLE IF NEEDED AFTER THE TERMINATION OF THE 
STUDY?  YES 
 
D6 (B) IF YES, PLEASE STATE THE INTERVENTION YOU ARE 
REFERRING TO AND STATE WHO WILL BEAR THE COST OF 
PROVISION OF THIS INTERVENTION? 
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The control group will be offered the intervention post data collection 
period. 
 
 
D7.  PLEASE COMMENT ON HOW INDIVIDUAL RESULTS WILL BE 
MANAGED.  
 
Participants Consultant Neurologists will be informed of outcome of the 
intervention, as part of routine clinical practice. 
 
D8.  PLEASE COMMENT ON HOW AGGREGATED STUDY RESULTS 
WILL BE MADE AVAILABLE. 
 
Results will be submitted as part of the data of a Masters thesis to RCSI.  
Publication via poster presentations and peer reviewed journals. 
 
D9.  WILL THE RESEARCH PARTICIPANT'S GENERAL 
PRACTITIONER BE INFORMED THE RESEARCH PARTICIPANT IS 
TAKING PART IN THE STUDY (IF APPROPRIATE)?  NO  
 
D10.  WILL THE RESEARCH PARTICIPANT'S HOSPITAL 
CONSULTANT BE INFORMED THE RESEARCH PARTICIPANT IS 
TAKING PART IN THE STUDY (IF APPROPRIATE)? 
 YES  
 
 
11 SECTION E data protection 
 
SECTION E IS MANDATORY 
 
IMPORTANT NOTE:  This application form permits the applicant to delete 
individual questions within each section depending on their response to the 
preceding questions.  Please respond to each question carefully and refer to 
the accompanying Guidance Manual for more in-depth advice prior to 
deleting any question.   
 
 
12 SECTION E1  data processing - consent 
 
E1.1 (A)  WILL CONSENT BE SOUGHT FOR THE PROCESSING OF 
DATA? YES  
 
E1.1 (B) IF NO, PLEASE ELABORATE.   
 
Answer 
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13 SECTION E2 data processing - GENERAL 
 
 
E2.1  WHO WILL HAVE ACCESS TO THE DATA WHICH IS 
COLLECTED?  
 
 
The hard copies of data will be stored in a locked filing cabinet in the 
physiotherapy department where the PI and the Physiotherapy manager will 
have access to. All electronic data will be coded and stored on the PI 
password protected computer in the physiotherapy department. The PI and 
research supervisor (Dr Rose Galvin) will have access to the coded data 
E2.2  WHAT MEDIA OF DATA WILL BE COLLECTED? 
 
Computerised spreadsheets and hard copy paper forms 
 
E2.3 (A) WOULD YOU CLASS THE DATA COLLECTED IN THIS 
STUDY AS anonymous, irrevocably anonymised, pseudonymised, 
coded or identifiable data? 
  
Coded 
 
E2.3 (B) IF ‘CODED’, PLEASE CONFIRM WHO WILL RETAIN THE 
‘KEY’ TO RE-IDENTIFY THE DATA? 
   
The PI and the ‘key’ will remain in Tallaght hospital and be held on a 
password protected computer, separately from the original data. 
 
E2.4  WHERE WILL DATA WHICH IS COLLECTED BE STORED? 
   
Electronic data will be stored on a password protected computer in the 
Physiotherapy Deaprtment.Hard copies will be held in a locked cabinet in 
the Physiotherapy department, where PI  and Physiotherapy manager will 
have access only.  
 
E2.5   PLEASE COMMENT ON SECURITY MEASURES WHICH HAVE 
BEEN PUT IN PLACE TO ENSURE THE SECURITY OF COLLECTED 
DATA. 
   
As above 
 
E2.6 (A) WILL DATA COLLECTED BE AT ANY STAGE LEAVING THE 
SITE OF ORIGIN?    
NO 
 
E2.6 (B) IF YES, PLEASE ELABORATE. 
   
 
 
91 
 
E2.7   WHERE WILL DATA ANALYSIS TAKE PLACE AND WHO WILL 
PERFORM DATA ANALYSIS (IF KNOWN)? 
  
In Tallaght hospital by the Principal investigator. 
   
E2.8 (A) AFTER DATA ANALYSIS HAS TAKEN PLACE, WILL DATA 
BE DESTROYED OR RETAINED? 
 
Retained and destroyed 
 
E2.8 (B) PLEASE ELABORATE.  
 
Clinical data will be retained as part participant healthcare records as per 
routine clinical practice. Research data will be destroyed 
 
E2.8 (C) IF DESTROYED, HOW, WHEN AND BY WHOM WILL IT BE 
DESTROYED? 
 
THE PI 
   
 
E2.8 (D) IF RETAINED, FOR HOW LONG, FOR WHAT PURPOSE, 
AND WHERE WILL IT BE RETAINED?   
 
Hard data in a locked filing cabinet in the Physiotherapy department, 
electronic data on a password protected computer in the Physiotherapy 
Department for five years after the period of data collection. This timeframe 
is stipulated by the Royal College of Surgeons in Ireland with respect to 
good research practice when conducting a research study.  
 
 
 
 
 
E2.9   PLEASE COMMENT ON THE CONFIDENTIALITY OF 
COLLECTED DATA. 
  
The following measures will be taken to ensure the confidentiality of the data: 
 Participants will be allocated a reference code.  
 Names and other details that may identify the participants will be removed.  
 Use of codes is meaningful only to the researcher.   
 All data collected saved in limited access computer files.   
 All written documentation held in secured filing cabinets.  
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 Access to the study data will be restricted to principal investigator and the supervisor 
involved in the study only 
 
    
E2.10 (A) WILL ANY OF THE INTERVIEW DATA COLLECTED 
CONSIST OF AUDIO RECORDINGS / VIDEO RECORDINGS? NO 
 
   
 
E2.11 (A) WILL ANY OF THE STUDY DATA COLLECTED CONSIST OF 
PHOTOGRAPHS/ VIDEO RECORDINGS?   NO 
 
 
14 SECTION e3 ACCESS TO HEALTHCARE RECORDS 
 
 
E3.1 (A) DOES THE STUDY INVOLVE ACCESS TO HEALTHCARE 
RECORDS (HARD COPY / ELECTRONIC)?  YES  
 
E3.1 (B) IF YES, PLEASE ELABORATE.  
  
Access to medical charts to obtain information on participants’ medical 
history is part of routine medical care. 
 
E3.1 (C) WHO WILL ACCESS THESE HEALTHCARE RECORDS? 
    
Anne Belton 
 
E3.1 (D) WILL CONSENT BE SOUGHT FROM PATIENTS FOR 
RESEARCH TEAM MEMBERS TO ACCESS THEIR HEALTHCARE 
RECORDS?  NO 
 
E3.2 (A) WHO OR WHAT LEGAL ENTITY IS THE DATA CONTROLLER 
IN RESPECT OF THE HEALTHCARE RECORDS? 
   
Tallaght Hospital 
 
E3.2 (B) WHAT MEASURES HAVE BEEN PUT IN PLACE BY THE 
DATA CONTROLLER WHICH MAY MAKE ACCESS TO HEALTHCARE 
RECORDS PERMISSIBLE WITHOUT CONSENT? 
   
Access to healthcare records is part of routine care. 
 
 
15 SECTION f HUMAN BIOLOGICAL MATERIAL 
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16 f1 Bodily Tissue / Bodily Fluid Samples - general 
 
 
F1 1 (a) Does this study involve human biological material?  NO 
 
If answer is No.  Please delete following questions in Section F. 
 
 
 
 
 
 
 
17 section G radioactive material / diagnostic or 
therapeutic ionising radiation 
 
 
18 G1 radioactive material / diagnostic or therapeutic 
ionising radiation - general 
 
 
G1.1  (a) Does this study/trial involve exposure to radioactive 
materials  or  does this study/trial involve other diagnostic or 
therapeutic ionising radiation?  NO 
 
If the answer to question G1.1(a) is No,  please delete the following questions in this Section. 
 
 
 
H1 (A) IS THE FOCUS OF THIS STUDY/TRIAL TO 
INVESTIGATE/EVALUATE A MEDICAL DEVICE?  NO 
If the answer to question H1 (a) is No,  please delete the following questions in this Section. 
 
 
19 SECTION I MEDICINAL PRODUCTS / COSMETICS / 
FOOD AND FOODSTUFFS 
 
Section I is designed to assist applicants in ascertaining if their research study is in fact a 
clinical trial of a medicinal product.  Section I is optional.  Please delete if this section does not 
apply. 
 
20 SECTION I.1 NON-INTERVENTIONAL TRIALS OF 
MEDICINAL PRODUCTS 
 
I1.1 (a)  Does this study involve a medicinal product? No 
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21 SECTION I.2 COSMETICS 
 
I2.1 (a)  Does this study involve a cosmetic? No 
 
 
 
 
22 SECTION I.3 FOOD AND FOOD SUPPLEMENTS 
 
I3.1 (a) Does this study involve food or food supplements?  No 
 
 
 
23 SECTION j INDEMNITY 
 
SECTION J IS MANDATORY 
 
IMPORTANT NOTE:  This application form permits the applicant to delete 
individual questions within each section depending on their response to the 
preceding questions.  Please respond to each question carefully and refer to 
the accompanying Guidance Manual for more in-depth advice prior to 
deleting any question.   
 
 
J1 (A) IS EACH SITE IN WHICH THIS STUDY IS TO TAKE PLACE 
COVERED BY THE CLINICAL INDEMNITY SCHEME (CIS)?  YES  
 
J1 (B) IF THE ANSWER IS ‘NO’ FOR ANY SITE, WHAT OTHER 
ARRANGEMENTS ARE IN PLACE IN TERMS OF INDEMNITY / 
INSURANCE?   
 
 
 
J2 (A) IS EACH MEMBER OF THE INVESTIGATIVE TEAM COVERED 
BY THE CLINICAL INDEMNITY SCHEME (CIS)?  YES / 
 
J2 (b) If no, do members of the investigative team not covered 
by the Clinical Indemnity Scheme (CIS) have either current 
individual medical malpractice insurance (applies to medical 
practitioners) or current professional liability insurance either 
individually or as provided by their hosting/employing institution 
(generally applies to allied healthcare professionals, university 
employees, scientists engineers etc.)? 
 
The investigator carrying out this piece of research is an employee of AMNCH and a 
qualified physiotherapist. She is a member of the Irish Society of Chartered 
Physiotherapists (ISCP). She is covered under the indemnity of Tallaght  
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J3 (A) WHO OR WHAT LEGAL ENTITY IS THE SPONSOR OF THIS 
RESEARCH STUDY?  
  
Tallaght Hospital 
 
 
J3 (B) WHAT ADDITIONAL INDEMNITY ARRANGEMENTS HAS THE 
SPONSOR PUT IN PLACE FOR THIS RESEARCH STUDY IN CASE OF 
HARM BEING CAUSED TO A RESEARCH PARTICIPANT (IF ANY)?  
 
This research study is conducted in part fulfilment of the requirements of a 
Masters in Neurology and Gerontology from the Royal College of Surgeons 
in Ireland. The researcher, a registered student at RCSI is also covered by 
the indemnity provided by RCSI.  
  
 
 
24 SECTION k COST AND RESOURCE IMPLICATIONS and 
funding 
 
SECTION K IS MANDATORY 
 
IMPORTANT NOTE:  This application form permits the applicant to delete 
individual questions within each section depending on their response to the 
preceding questions.  Please respond to each question carefully and refer to 
the accompanying Guidance Manual for more in-depth advice prior to 
deleting any question.   
 
 
K1 (A)  ARE THERE ANY COST / RESOURCE IMPLICATIONS 
RELATED TO THIS STUDY?   NO 
 
K1 (B) IF YES, PLEASE ELABORATE.   
 
Answer 
 
 
K2 (a) Is funding in place to conduct this study?  NO 
K2 (b) If no, has funding been sought to conduct this study?  NO 
 
K2 (c) Please state the source of funding (industry, grant or 
other) and the amount of funding.   
 
Answer 
 
K2 (d) Is the study being funded by an external agency?  NO 
K2 (e) Is the external agency a ‘for profit’ organisation? NO 
K2 (f) Do any conflicts of interest exist in relation to funding?  
Please elaborate. 
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n/a 
 
 
K2 (g) Please provide additional details in relation to 
management of funds.  
 
n/a 
 
 
K3.  Please provide details of any payments (monetary or 
otherwise) to investigators.  
  
n/a 
 
 
K4.  Please provide details of any payments (monetary or 
otherwise) to participants.  
 
n/a 
 
 
25 SECTION l ETHICAL ISSUES 
 
SECTION L IS MANDATORY 
 
L1.   Please identify any particular additional ethical issues that this 
project raises and discuss how you have addressed them.  
 
The study involve participation in a balance class, therefore there is a risk of 
falling. All participants will be supervised at all times and routine 
environmental risk assessments will be conducted by the Physiotherapist at 
the beginning of each session. Participants will also be encouraged to 
indicate of they wish to have a rest break or stop the activity. 
 
PLEASE ENSURE THIS APPLICATION FORM IS FULLY COMPLETED AS 
INCOMPLETE SUBMISSIONS WILL NOT BE REVIEWED.   
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Appendix 8 
Data Collection Outcome measures 
 Brief  
BEST 
UPDRS TUG TUG 
C 
TUG 
M 
Pd-39 FES 
1.  Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post 
1.                
2.                
3.                
4.                
5.                
6.                
7.                
8.                
9.                
10.               
11.               
12.               
13.               
14.               
15.               
16.               
17.               
18.               
19.               
20.               
21.               
22.               
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23.               
24.               
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Appendix 9 Brief BESTest 
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Appendix 10 MDS-UPDRS
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Appendix 11 
Timed Up and Go tests 
Directions: 
The Timed ‘Up and Go’ test measures, in seconds, the time taken for an individual to stand up 
from a standard arm chair (approximate seat height of 46cm, arm height 65cm), walk a distance 
of 3 metres, turn, walk back to the chair and sit down. The subject wears their regular footwear 
and uses their customary aid (none, cane, walker). No physical assistance is given. They start 
with their back against the chair, their arms resting on the armrests, and their walking aid at 
hand. They are instructed that, on the word “go” they are to get up and walk at a comfortable 
and safe pace to a line on the floor 3 metres away, turn, return to the chair and sit down again. 
The subject walks through the test once before being timed in order to become familiar with the 
test. Either a stopwatch or a wristwatch with a second hand can be used to time the trial. 
Instructions to the patient: 
Timed Up and Go: “Walk as quickly and safely as possible to the marked line, turn around, 
walk back to the chair and sit down.” 
Timed Up and Go Cognitive: ““Walk as quickly and safely as possible to the marked line, turn 
around, walk back to the chair and sit down. In addition, count backwards in threes from the 
number given.” 
Timed Up and Go Manual: “Stand up, pick up the glass, and then walk as quickly and safely 
as possible to the marked line, turn around, walk back to the chair, put the glass down and sit 
down. 
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Appendix 12 
Parkinson’s Disease Quality of Life Questionnaire (PDQ-39) 
Due to having Parkinson’s disease,  
how often during the last month have you… 
Please tick one box for each question 
Please check that you have ticked one box for each question before going onto the 
next page. 
 
Never Occasionally Sometimes Often 
Always  
or cannot  
do at all 
1. 
Had difficulty doing the leisure 
activities which you would like  
to do? 
 
     
2. 
Had difficulty looking after your 
home, e.g. DIY, housework, cooking? 
 
     
3. 
Had difficulty carrying bags of 
shopping? 
 
     
4. Had problems walking half a mile? 
 
     
5. Had problems walking 100 yards? 
 
     
6. 
Had problems getting around the 
house as easily as you would like? 
 
     
7. 
Had difficulty getting around in 
public? 
 
     
8. 
Needed someone else to accompany 
you when you went out? 
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Due to having Parkinson’s disease,  
how often during the last month have you… 
Please tick one box for each question 
 
Never 
Occasionall
y Sometimes Often 
Always  
or cannot  
do at all 
9. 
Felt frightened or worried about 
falling over in public? 
 
     
10. 
Been confined to the house 
more than you would like? 
 
     
11. Had difficulty washing yourself? 
 
     
12. Had difficulty dressing yourself? 
 
     
13. 
Had problems doing up buttons  
or shoe laces? 
 
     
14. Had problems writing clearly? 
 
     
15. 
Had difficulty cutting up your 
food? 
 
     
16. 
Had difficulty holding a drink 
without spilling it? 
 
     
17. Felt depressed? 
 
     
18. Felt isolated and lonely? 
 
     
Please check that you have ticked one box for each question  
before going onto the next page. 
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Due to having Parkinson’s disease,  
how often during the last month have you… 
Please tick one box for each question 
 
Never Occasionally Sometimes Often Always 
19. Felt weepy or tearful? 
 
     
20. Felt angry or bitter? 
 
     
21. Felt anxious? 
 
     
22. Felt worried about your future? 
 
     
23. 
Felt you had to conceal your 
Parkinson’s from people? 
 
     
24. 
Avoided situations which involve 
eating or drinking in public? 
 
     
25. 
Felt embarrassed in public due to 
having Parkinson’s disease? 
 
     
26. 
Felt worried by other people’s 
reaction to you? 
 
     
27. 
Had problems with your close 
personal relationships? 
 
     
Please check that you have ticked one box for each question  
before going onto the next page. 
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Due to having Parkinson’s disease,  
how often during the last month have you… 
Please tick one box for each question 
 
Never Occasionally Sometimes Often Always 
28. 
Lacked support in the ways you 
need from your spouse or partner? 
If you do not have a spouse  
or partner, please tick here   
 
     
29. 
Lacked support in the ways you 
need from your family or close 
friends? 
 
     
30. 
Unexpectedly fallen asleep during 
the day? 
 
     
31. 
Had problems with your 
concentration, e.g. when reading  
or watching TV? 
 
     
32. Felt your memory was bad? 
 
     
33. 
Had distressing dreams or 
hallucinations? 
 
     
34. Had difficulty with your speech? 
 
     
35. 
Felt unable to communicate with 
people properly? 
 
     
 
Please check that you have ticked one box for each question  
before going onto the next page. 
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Due to having Parkinson’s disease,  
how often during the last month have you… 
Please tick one box for each question 
 
Never Occasionally Sometimes Often Always 
36. Felt ignored by people? 
 
     
37. 
Had painful muscle cramps or 
spasms? 
 
     
38. 
Had aches and pains in your joints 
or body? 
 
     
39. Felt unpleasantly hot or cold? 
 
     
 
 
Please check that you have ticked one box for each question. 
 
Thank you for completing the questionnaire. 
 
 
 
 
 
PDQ-39 © Copyright, Isis Innovation Limited 1993. All Rights Reserved. 
The authors, being Professor Crispin Jenkinson, Professor Ray Fitzpatrick and Ms Viv 
Peto, have asserted their moral rights. 
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Appendix 13 
 
Falls Efficacy Scale 
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Appendix 14 
FALLS CALENDAR 
SEPTEMBER 2013 
Your name: 
 
Please place a tick () for each fall in the appropriate date box below. 
Remember, a fall is “an unexpected event in which you come to rest on 
the ground, floor, or lower level.” 
 
September 2013 
Sun  Mon  Tue  Wed  Thu  Fri  Sat 
            1 
             
2  3  4  5  6  7  8 
             
9  10  11  12  13  14  15 
             
16  17  18  19  20  21  22 
             
23  24  25  26  27  28  29 
             
30  31           
 
I had NO falls this month 
At the end of the month, please return the calendar sheet and return it in the 
reply paid envelope. 
A list of questions to answer about every recorded fall: 
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 Where were you when you fell? 
____________________________________________________________ 
 What were you trying to do at the time? 
____________________________________________________________ 
 What do you think caused you to fall? 
____________________________________________________________ 
 How did you land? 
____________________________________________________________ 
 What injuries did you sustain? 
____________________________________________________________ 
 How did you get up again? 
____________________________________________________________ 
 What health care did you receive? 
____________________________________________________________ 
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Appendix 15 
Data Collection Form 
The effect of a balance exercise class on activity limitations in people 
with Parkinson’s disease. 
ID Code:  ____________ 
Date:  _____________ 
 
Demographics 
Age: _____________     Male:   Female:  
 
Parkinson’s Information 
Hoehn and Yahr Stage:      _______________ 
Number of falls in the last 6 months:    _______________ 
Name of medication:       _______________ 
Walking Aid: Y N N/A     Type:   _______________ 
MMSE Score:       _______________ 
Years since diagnosis                                                              ________________      
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